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CHAPTER 1: INTRODUCTION 
In 1895 a breakthrough in signal analysis occurred with the beginning of the ability to measure the 
electrical signal of the heart through the electrocardiogram (ECG) (Hurst, 1998). This historical 
achievement revealed that heart rate (HR) is noticeably irregular, which was unlike the common 
belief at the time (Shaffer et al., 2014). It is well-established today that a healthy heart is not like 
a metronome producing monotonously regular beats (Shaffer et al., 2014). The irregularity of HR 
is the result of the dynamic interplay between the sympathetic and parasympathetic divisions of 
autonomic nervous system (ANS) (Clifford, 2002; Kamath et al., 2012; Shaffer et al., 2014). The 
interaction between both systems is modulated by regulatory systems of the body including the 
cardiovascular, respiratory, endocrine, and central nervous systems and chemoreceptors and 
baroreceptors (Clifford, 2002; Kamath et al., 2012; McCraty, 2015; Shaffer et al., 2014). The 
sinoatrial (SA) node integrates the inputs from the ANS and the modulations from the 
aforementioned regulatory systems to adjust HR against the constantly changing internal and 
external environment for maintaining homeostasis (Maud & Foster, 2006; Shaffer et al., 2014). 
This adjustment causes an oscillatory pattern in the HR or beat-to-beat fluctuations in the time 
period between sequential heartbeats, termed heart rate variability (HRV) (Maud & Foster, 2006; 
Shaffer et al., 2014). Since it is not viable to detect SA node action potentials, the fiducial point of 
heartbeat (i.e., P-wave) on the ECG should ideally be determined for calculating HRV (Clifford et 
al., 2006; Peltola, 2012). However, the amplitude of P-waves is too low for computer algorithms 
to identify them correctly (Clifford et al., 2006; Peltola, 2012). Therefore, the R-waves are used to 
measure HRV due to their distinguishable amplitude. For this reason, HRV can also be called R-
R variability.  
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  HRV can be analyzed by time, frequency, and non-linear domain measures calculated 
from the ECG R-R intervals. Time domain measures demonstrate the variance between sequential 
R-R intervals and are used to quantify the amount of variability during the recording (Maud & 
Foster, 2006; McCraty, 2015). The most prominent time domain  measures include:  1) standard 
deviation of normal R-R intervals (SDNN); 2) root mean square of successive differences in 
normal R-R intervals (RMSSD); and 3) percentage of successive normal R-R intervals greater than 
50 ms (pNN50%). Time domain measures are easy to calculate but are not useful to quantify the 
interplay between sympathetic and parasympathetic divisions (Maud & Foster, 2006; McCraty, 
2015).  
The frequency domain measures are calculated from the power or variance spectral density 
analysis of the R-R interval time series (Maud & Foster, 2006; McCraty, 2015). This analysis 
provides information on how the power (i.e., variance of a rhythm) is distributed as a unit of 
frequency in the hertz (Hz) (Maud & Foster, 2006; McCraty, 2015). Four frequency bands are 
determined in the power spectral analysis of the R-R interval time series, including: 1) high 
frequency (HF ms2, 0.15-0.40 Hz); 2) low frequency (LF ms2, 0.04-0.15 Hz); 3) very low 
frequency (VLF ms2, 0.0033-0.04 Hz); and 4) ultra-low frequency (ULF, ≤0.0033). The discussion 
over the use and representation of LF ms2 is still ongoing, but mostly the claim is that LF ms2 is 
generated by both the sympathetic nervous system (SNS) and parasympathetic nervous system 
(PNS) as well as blood pressure regulation through baroreceptors or by baroreflex modulation only 
(Heathers, 2014; Pagani et al., 2012; Reyes del Paso et al., 2013). However, overwhelming 
majority of the researchers agree that HF ms2 reflects parasympathetic or vagal modulation 
(Akselrod et al., 1981; Malik, 1996; Heathers, 2014). In addition, HF ms2 is also known as 
respiratory band because of the strong linear relationship between vagal control of the heart and 
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respiratory variation observed in the time difference between two successive R-waves (i.e., 
respiratory sinus arrythmia) (Shaffer et al., 2014; Shaffer & Ginsberg, 2017). The normalized units 
of LF and HF and ratio of LF and HF frequency bands (LF/HF) are also commonly reported 
frequency domain measures. Although its representation has been a matter of debate due to the 
disagreements regarding LF ms2 the LF/HF ratio is used as a marker of sympathovagal modulation, 
the autonomic state resulting from the mutually opposing influences of the sympathetic and 
parasympathetic activities (Heathers, 2014; Pagani et al., 1984; Pagani et al., 1986) .   
Besides traditional time and frequency domain variables, there are also non-linear 
measures that show the unpredictability of the R-R interval time series caused by the interactions 
among the complex regulatory systems of HRV (Shaffer et al., 2014; Shaffer & Ginsberg, 2017). 
The most common non-linear HRV measures consist of: 1) standard deviation 1 (SD1); 2) standard 
deviation 2 (SD2); and 3) the ratio of SD2 and SD1 (SD2/SD1). These measures of HRV are 
analyzed using Poincare plot method, providing a graph displaying the correlation between 
sequential R-R intervals (Shaffer et al., 2014; Shaffer & Ginsberg, 2017). Even though the non-
linear measures have become increasingly reported the physiological representations of such 
measures are still ambiguous (Shaffer et al., 2014; Shaffer & Ginsberg, 2017). Nevertheless, 
current literature indicates that SD1 represents the baroreflex sensitivity, diastolic blood pressure, 
and HR minimum and maximum; SD2 represents baroreflex sensitivity; and SD2/SD1 represents 
autonomic modulation during 5 min of recording (Brennan et al., 2001; Guzik et al., 2007; Shaffer 
& Ginsberg, 2017).   
Low HRV is associated with reduced ability for an organism to deal with the internal and 
external causes of stress and counter diseases or recover in timely fashion (McCraty, 2015). The 
clinical significance of HRV was highlighted by Hon & Lee for the first time in 1965. They 
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observed that low HRV was the first sign of fetal stress while the HR had no change during labor 
and delivery (Lee & Hon, 1965).  
Therefore, HRV has become a popular physiological marker for clinicians and researchers 
studying clinical populations 1) to determine the early signs of a pathology, the presence of a 
chronic disease, or health condition and its treatment prognosis (Pumprla et al., 2002); and 2) to 
evaluate the ability to cope with stress and the effectiveness of an intervention (e.g., exercise, 
medical procedure) (Mourot et al., 2004; Mourot & Regnard, 2004). Since then, HRV has been 
associated with various diseases, cardiovascular disease risk factors, and psychological disorders. 
The current literature indicates that low HRV is associated with diabetic neuropathy (Ewing et al., 
1976), myocardial infarction (Pecyna, 2006), sudden cardiac death (Kudaiberdieva et al., 2007), 
congestive heart failure (Frenneaux, 2004), metabolic disorders (Stuckey et al., 2014), chronic 
renal failure (Axelrod et al., 1987), fibromyalgia (Kang et al., 2016) , non-cardiac chest pain (Ong 
et al., 2013), asthma (Kazuma et al., 1997), anxiety (Cohen & Benjamin, 2006), depression 
(Carney et al., 2001) , and of relevance to this study, hypertension (Schroeder et al., 2003; 
Terathongkum & Pickler, 2004). In addition, HRV has been a useful measure for coaches in a 
variety of sport settings since it provides them with an ability to assess and monitor their athletes’ 
cardiorespiratory fitness (De Meersman, 1993), training intensity, type, and time (Vesterinen et 
al., 2016), training periodization (Kiviniemi et al., 2007), performance (Plews et al., 2013), 
overtraining (Mourot et al., 2004), and recovery (Mourot & Regnard, 2004).  
1.1.Statement of the Problem 
Due to the recent technological advances in signal analysis researchers tend to choose HR monitors 
over the gold standard criterion ECG for measuring HRV because of their ability to record R-R 
intervals (i.e., heartbeats) with easily available, simple-to-use, affordable, and wireless features. 
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The apparent ease of accessing HRV via HR monitors has dramatically extended its study in 
clinical and athletic populations. Indeed, a recent PubMed search (May 22nd, 2019) showed that 
the number of publications associated with HRV rose from 39 in 1977, a year of the first Polar 
(Polar Electro Oy) HR monitor to 1785 in 2018. Additionally, the number of studies published 
during the last 15 years from 2003 to 2018 (n=15,012) was two times higher than those published 
during the 25 years from 1977 to 2003 (n=6,876). The substantial increase in the number of 
publications during the last 15 years corresponds to the introduction of new HR monitor 
technologies such as Polar RS800TM, S810TM,S810iTM, and the latest version of V800TM as well as 
HRV software packages such as Kubios HRV (ver 1.1). Given the increasing credibility of HR 
monitors to accurately detect the R-R intervals and the convenience of HRV software packages in 
analyzing HRV measures the trend in HRV use among researchers seems likely to continue. 
However, artifacts (i.e., random distortion of usual R-R intervals) with technical (e.g., missed 
beats) or physiological (e.g., non-sinus beats) origins can impair the ability of HR monitors to 
detect accurate R-R intervals to such a degree that HRV measures become no longer meaningful 
which may potentially diminish the usefulness of HRV. Hence, multiple researchers have stressed 
the necessity of distorted R-R intervals with technical or physiological origins to acquire reliable 
HRV measures (De Geus et al., 2019; Kumaravel & Santhi, 2010; Mateo & Laguna, 2003; Nabil 
& Reguig, 2015; Peltola et al., 2008; Salo et al., 2001).  
Several lines of evidence suggested that the manual correction (MC) of artifacts with visual 
identification of the R-R intervals combined with the choice of a proper correction method is the 
most accurate method for ensuring comparable HRV measures derived from R-R intervals 
between ECG and Polar HR monitors (De Geus et al., 2019; Nabil & Reguig, 2015; Peltola, 2012). 
Recently, (Giles et al., 2016) updated the MC methods developed by (Gamelin et al., 2006) by 
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adding two more corrections for artifacts that were discovered with the current Polar HR monitor 
V800TM among a healthy population. However, the MC is a laborious process and it requires a 
certain level of specialty and expertise, which led to the manufacturing of various HRV software 
packages offering easy-to-use automatic correction options to edit artifacts.   
Kubios is the most popular HRV software that is used to automatically correct artifacts 
cited in about 1000 studies (Kubios HRV [ver. 3.2] User’s Guide, 2019). The latest version of the 
software (Kubios HRV Premium [ver. 3.2]) released in January 2019 provides two options for 
correcting technical and physiological artifacts, the: 1) automatic correction (AC) and 2) threshold-
based correction (TBC) methods. The AC option was not available in the versions before the first 
release of commercial Kubios HRV Premium (ver. 3.0) in January 2017. The AC uses a time series 
with differences between sequential R-R intervals to identify artifacts, thereby separating the 
physiological and technical artifacts from the sinus rhythm (Kubios HRV User’s Guide, 2018). 
While missed beats are edited by adding new R-R intervals, extra beats are corrected by 
eliminating extra R-R intervals (Kubios HRV [ver. 3.2] User’s Guide, 2019). The TBC makes 
comparisons of each R-R interval against a local R-R interval average (Kubios HRV [ver. 3.2] 
User’s Guide, 2019). If an R-R interval exceeds or falls behind the local R-R interval average more 
than a selected threshold value, the particular R-R interval is plotted as an artifact for correction 
(Kubios HRV [ver. 3.2] User’s Guide, 2019). Several threshold values are available with this 
correction method, comprising:  1) very low (0.45 sec); 2) low (0.35 sec); 3) medium (0.25 sec); 
4) strong (0.15 sec); 5) very strong (0.05 sec); and 6) custom (a customized threshold in sec) 
(Kubios HRV [ver. 3.2] User’s Guide, 2019). With the TBC method, it is recommended to select 
the lowest threshold possible to avoid overcorrecting the normal R-R intervals (i.e., N-N intervals) 
after visually detecting the artifacts as higher thresholds can lead to measurement bias. Both 
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correction methods of Kubios HRV Premium (ver 3.2) replace the detected artifacts with 
interpolated R-R intervals using a cubic spline interpolation (Kubios HRV [ver. 3.2] User’s Guide, 
2019).  
The previous versions of Polar including S810TM (Gamelin et al., 2006; Kingsley et al., 
2005), S810iTM (Vanderlei et al., 2008), RS800CXTM (Vasconcellos et al., 2015), RS800GXTM (De 
Rezende Barbosa et al., 2016), and the current version V800TM HR monitors (Caminal et al., 2018); 
Giles & Draper 2017; Giles et al., 2016) have been validated among healthy individuals, showing 
good agreement between the corrected R-R intervals as well as HRV measures of the Polar HR 
monitors and simultaneously recorded 2-lead, 3-lead, 5-lead, and 12-lead ECGs. However, it has 
been reported that calculation of HRV measures with separate software packages led to 
incomparable results between ECG and several HR monitors in clinical and healthy populations 
(Sandercock et al., 2004; Wallén et al., 2012; Weippert et al., 2010). The current version Polar 
V800TM HR monitor has not been validated in clinical populations, particularly in individuals with 
hypertension. Moreover, it has been shown that the TBC of the previous version of Kubios HRV 
(ver 2.2) was not able to correct the certain artifacts properly even though it identified most 
artifacts correctly,  which resulted in large bias between the HRV measures of ECG and Polar 
V800TM (Giles & Draper, 2017).   
HRV is a useful physiological marker for assessing autonomic function. Although the 
mechanisms causing hypertension are not completely clear one of the potential mechanisms 
underlying hypertension is a dysregulation/disruption in autonomic function (Schroeder et al., 
2003). Therefore, validating a portable, non-invasive, easy-to-use technology such as Polar 
V800TM that can assess autonomic function in patients with hypertension may help clinicians and 
researchers better evaluate mechanisms underlying a patient's hypertension and more effectively 
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target therapeutic options. Moreover, since the clinical populations may have a greater number of 
artifacts than healthy individuals (Kamath & Fallen, 1995; Peltola et al., 2012), the accurate 
correction of artifacts for adults with hypertension is even more important to obtain valid HRV 
measures. This requires researchers to be able to choose a method of correction with the highest 
editing accuracy. Therefore, establishing the accuracy of the recent version of Kubios HRV 
Premium (ver 3.2) with its updated TBC and newly added AC methods and recently updated the 
MC method to correct artifacts from the Polar V800TM HR monitor can assist researchers studying 
HRV in adults with hypertension to select a method of correction that can produce HRV measures 
with highest agreeability between the Polar V800TM HR monitor and the gold standard ECG.  
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1.2.Specific Aims and Hypotheses 
Specific Aim 1: To compare the corrected and uncorrected (UN) R-R intervals obtained from Polar 
V800TM HR monitor to R-R intervals obtained from a 12-lead gold standard ECG among 
individuals with hypertension.  
We hypothesize: The Polar V800TM HR monitor will produce corrected R-R intervals consistent 
and UN R-R intervals inconsistent with a 12-lead ECG among adults with hypertension.  
Specific Aim 2: To compare the corrected and UN time, frequency, and non-linear domains of 
HRV measures derived from corrected and UN R-R intervals obtained from Polar V800TM HR 
monitor to time, frequency, and non-linear domains of HRV measures derived from R-R intervals 
obtained from 12-lead ECG among adults with hypertension.  
We hypothesize: The Polar V800TM HR monitor will produce time, frequency, and non-linear 
domains of HRV measures derived from corrected R-R intervals consistent and the HRV measures 
derived from UN R-R intervals inconsistent with time, frequency, and non-linear domains of HRV 
measures derived from a 12-lead ECG among individuals with hypertension.     
Specific Aim 3: To compare the MC and the Kubios HRV Premium (ver.3.2) TBC and AC 
methods to accurately and reliably correct the artifacts (i.e., distorted R-R intervals) obtained from 
V800TM HR monitor compared to R-R intervals obtained from 12-lead ECG. 
We hypothesize: The MC will correct artifacts obtained from V800TM HR monitor with a greater 
accuracy and reliability than the Kubios Premium (ver.3.2) TBC and AC methods compared to R-
R intervals obtained from 12-lead ECG.  
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CHAPTER 2: REVIEW OF THE LITERATURE 
2.1. Overview of Heart Anatomy and Physiology 
2.1.1. Heart Anatomy and Circulation 
The heart is divided into four chambers bordered by myocardium (i.e., heart muscle). These 
chambers include the upper left and right atria and lower left and right ventricles. The two atria 
receive venous blood returning to the heart, whereas the two ventricles pump the blood from the 
heart to lungs and arteries. Venous blood with a lower content of oxygen flows into right atrium 
and from there directly into the right ventricle where the pulmonary arteries carry the venous blood 
to the lungs for replacing oxygen and removing wastes (Kamath et al., 2012; Maud & Foster, 2006; 
McCraty, 2015).   
 
Figure 1. Heart Anatomy and Circulation. A: Aorta; B: left pulmonary artery; C: left pulmonary vein; D: inferior 
vena cava; E: right pulmonary vein; F: right pulmonary artery; G: superior vena cava. Credit: clipart-library.com 
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The oxygen-rich blood is moved into the left atrium through pulmonary veins and from there to 
the left ventricle where the aorta transports the blood to the systemic circulation to meet the oxygen 
needs of the tissues (Kamath et al., 2012; Maud & Foster, 2006; McCraty, 2015). Interatrial septum 
,interventricular septum, mitral, tricuspid, pulmonic, and aortic valves keep blood from flowing 
back into atria and ventricles (Kamath et al., 2012; Maud & Foster, 2006; McCraty, 2015).  
The heart cycle defines the period from the start of one heartbeat to the start of the next. It 
comprises ventricular contraction, a period where the left ventricle ejects blood from the heart 
(systole) and ventricular relaxation, a period where the left ventricle relaxes and refills with blood 
(diastole) (Kamath et al., 2012; Maud & Foster, 2006; McCraty, 2015). Myocardial (relating to 
the heart muscle) contractions are initiated by a series of electrical impulses, the rate of which 
determines the HR. The cells that generate the electrical impulses are called pacemakers. two 
internal pacemakers initiating the heartbeat are the sinoatrial node (SA), atrioventricular node 
(AV), and Purkinje fibers (Kamath et al., 2012; Maud & Foster, 2006; McCraty, 2015) (Figure 1).  
2.1.2. Autonomic Nervous System 
The cardiovascular center is located in the medulla oblongata, a long stem-like structure in the 
brainstem. It regulates the rate at which the heart beats through nervous and endocrine systems. 
The nervous system comprises central nervous system and peripheral nervous system (Kamath et 
al., 2012; Maud & Foster, 2006; McCraty, 2015). The main role of peripheral nervous system is 
to link the central nervous system to the limbs and organs, i.e., transmitting the signals between 
brain, spinal cord and the rest of the body (Kamath et al., 2012; Maud & Foster, 2006; McCraty, 
2015). The peripheral nervous system has two divisions: 1) somatic nervous system (voluntary 
motor system); and 2) ANS (involuntary motor system). The ANS branches into the SNS 
(responsible for fight or flight response) and PNS (responsible for rest and digests response) 
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(Kamath et al., 2012; Maud & Foster, 2006; McCraty, 2015). The PNS response exerts its influence 
< 1 sec and it is short lasting, but after the onset of the SNS activation, there is a waiting period of 
around 5 sec ensued by a stable increase in HR for the next 20-30 sec (Shafer et al., 2014). 
However, HR regulation cannot be interpreted as a linear sum of two opposite effects as elevated 
parasympathetic activity may not always indicate a decreased sympathetic activity, or vice versa 
(i.e., increase in PNS can be related to decrease, increase, or no change in SNS) (Heathers, 2014). 
The PNS reactivation during HR recovery as the SNS stays elevated after a bout of exercise is an 
example of non-linear interactions between SNS and PNS (Heathers, 2014). Therefore, it is not 
appropriate to describe the relationship between the SNS and PNS as demonstrated by a seesaw 
where one side moves up another side moves down.  
2.1.3. Electrical Signal of the Heart 
The SA node is located in the upper right area of the right atrium. In a healthy heart, the SA node 
initiates each heartbeat, generating the depolarization (contraction) of the myocardium (Kamath et 
al., 2012; Shaffer et al., 2014). The intrinsic frequency of SA node is 60-100 beat per minute. If 
the SA node is injured and unable to regulate the HR, the AV node, the intrinsic frequency of 
which is 40-60 beats per minute (bpm) can replace the injured SA node as pacemaker (Kamath et 
al., 2012; Shaffer et al., 2014). In addition, if the pace making ability of AV is compromised then 
Purkinje fibers, the intrinsic rate of which is 15-40 bpm can regulate the HR (Kamath et al., 2012; 
Shaffer et al., 2014). Of note, however, Purkinje fibers are triggered as the last resort in the case 
of failed SA and AV nodes. The electrical stimulus produced by SA node moves through the atria 
to the AV node in approximately 0.03 sec and triggers AV node discharge (Kamath et al., 2012; 
Shaffer et al., 2014). Depolarization of the left and right atria of myocardium produce P-wave 
(atrial systole) of the ECG. The electrical impulse is rapidly propagated through the bundle of His 
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and Purkinje fibers descending down both sides of the septum (Kamath et al., 2012; Shaffer et al., 
2014). As the electrical impulse travels through this region it conducts the electrical impulse over 
the ventricles approximately 0.2 sec after the occurrence of the P-wave (Kamath et al., 2012; 
Shaffer et al., 2014). The Purkinje fibers depolarize ventricular myocytes and result in the QRS 
complex ensued by S-T segment formation (Kamath et al., 2012; Shaffer et al., 2014).  
 
 
Figure 2. Electrical Conduction System of the Heart. Credit: nurseslearning.com 
 
Ventricular systole starts at the beginning of the QRS complex and expands in the direction of the 
S-T segment (Kamath et al., 2012; Shaffer et al., 2014). Ventricular repolarization produces the T-
wave approximately 0.4 sec after the P-wave occurs. Finally, ventricular diastole occurs 0.6 s after 
the start of the P-wave (Kamath et al., 2012; Shaffer et al., 2014). (Figure 2).  
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 A dynamic interplay between the SNS and PNS systems is considered to be a sign of a 
healthy organism (Kamath et al., 2012; Shaffer et al., 2014). Variation in the HR is a demonstration 
of the net impact of the interaction between SNS and PNS (McCraty, 2015). The rate of SA node 
without any nervous and hormonal influence is around 100 to 120 bpm at rest (Kamath et al., 
2012). However, the predominant branch of the ANS at rest, the PNS inhibits some of the electrical 
impulses of SA node and thereby resulting in the net resting HR of 60-100 bpm in healthy 
individuals (Kamath et al., 2012). This shows that the predominant neural output comes from the 
PNS while the SNS is tonically active (i.e., minimum baseline activity) at rest in health individuals 
(Kamath et al., 2012).    
The PNS (originating from cranial vagal nerve) slows the HR by stimulating intrinsic 
cardiac conduction system that extends toward the SA node, AV, node, and atrial myocardium 
(Kamath et al., 2012; Shaffer et al., 2014). Elevated efferent stimulation in the nerves of the cardiac 
nervous system activates acetylcholine release, binding to muscarinic receptors (M2) located on 
the myocardial fibers (Kamath et al., 2012; Shaffer et al., 2014). This leads to a decrease in the 
depolarization of the SA and AV nodes, and thereby, slows the HR. The response to vagal 
innervation is instantaneous, takes place within a heart cycle, and therefore, impacts one or two 
heartbeat following its onset (Kamath et al., 2012; Shaffer et al., 2014). Once vagal innervation 
stops, the HR quickly decreases to its baseline level. The HR can also increase if the vagal 
innervation is diminished or blocked. Therefore, the difference in the time between sequential 
heartbeats are parasympathetically mediated (Kamath et al., 2012; Shaffer et al., 2014). Elevated 
efferent sympathetic nerves (originating from the T1-T4 segments of the spinal cord) stimulate the 
SA and AV nodes through the cardiac nervous system (Kamath et al., 2012; Shaffer et al., 2014). 
Action potentials resulting from sympathetic stimulation cause the release of norepinephrine, 
15 
 
binding to beta adrenergic receptors (beta 1) found on myocardial fibers (Kamath et al., 2012; 
Shaffer et al., 2014). This results in an increase in the depolarization of SA and AV nodes and 
thereby elevating HR (Kamath et al., 2012; Shaffer et al., 2014).  
2.2. Overview of HRV 
A healthy organism consists of a physiological control system that never rests nor operates in a 
static manner (Kamath et al., 2012; Shaffer et al., 2014). For instance; a healthy heart beats highly 
irregularly producing variation between one beat and the next as opposed to beating like a 
metronome with no variations created (Shaffer et al., 2014). Thus, HR is an indicative biomarker 
of the interaction between the sympathetic and parasympathetic divisions of the ANS (Kamath et 
al., 2012; Shaffer et al., 2014). The interaction between both branches is constantly occurring in 
an effort to reach a relatively stable environment interrupted by internal and external challenges 
(Kamath et al., 2012; Shaffer et al., 2014).  This dynamic interaction between the PNS and SNS 
results in fluctuations in the length of the intervals between heartbeats or beat-to-beat changes, this 
is termed HRV. Afferent signals occurring from a various physiological processes including blood 
pressure oscillations, thermoregulation, respiration, and circadian rhythm also contribute to the 
variability in the HR (Kamath et al., 2012; Shaffer et al., 2014). Therefore, HRV can provide a 
window into cardiovascular and respiratory control mechanisms and as a means to examine the 
interaction between sympathetic and parasympathetic divisions of the ANS (Kamath et al., 2012; 
Shaffer et al., 2014).  
2.2.1. Clinical Application of HRV 
An optimum level of variability created by the regulatory systems of a body including the 
autonomic, cardiorespiratory, endocrine, and central nervous systems as well as chemoreceptors 
and baroreceptors is essential for a healthy organism (Heathers, 2014) Whereas a high level of 
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variability can be a sign of inefficient physiological functioning and energy utilization, low 
variability can be an indication of a pathology (Heathers, 2014) .   
 The clinical significance of the HRV was first reported by (Lee & Hon, 1965) when they 
examined fetal HRV during labor and delivery and its association with fetal health. They found 
that changes in HRV precedes fetal stress before any changes take place in the HR itself (Lee & 
Hon, 1965). Subsequently in 1970, it was shown that HRV predicted autonomic neuropathy in 
patients with diabetes prior to the beginning of symptoms (Ewing et al., 1976). Additionally, low 
HRV was linked with higher mortality in patients with acute myocardial infarction (Berntson et 
al., 2008), and the chance of sudden cardiac death in patients with acute myocardial infarction 
(Sessa et al., 2018).  
 Since then low HRV has been shown to be a valid and independent predictor of diverse 
pathological conditions including chronic renal failure (Axelrod et al., 1987), fibromyalgia (Kang 
et al., 2016), asthma (Kazuma et al., 1997), gastrointestinal disorders (Polster et al., 2018), 
congestive heart failure (Frenneaux, 2004), sudden cardiac death (Sessa et al., 2018), anxiety 
(Cohen & Benjamin, 2006), depression (Carney et al., 2001), and hypertension (Schroeder et al., 
2003; Terathongkum & Pickler, 2004).  
2.2.1.1. Effects of Hypertension on HRV 
Hypertension is the most commonly observed cardiovascular disease risk factor in the United 
States (Arnett et al., 2019) as currently 46% of American adults have hypertension (Arnett et al., 
2019), making it a significant health problem in the country (Arnett et al., 2019). Hypertension 
can increase the likelihood of developing coronary artery disease, stroke, renal failure, and cardiac 
heart failure (Clifford, 2002). However, the underlying etiology for the development of 
hypertension are largely unknown. One of the hypotheses regarding the initiation, progression, and 
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maintenance of hypertension is alterations in the neural control of the blood pressure (Kamath et 
al., 2012). These neural changes generally emerge as excessive sympathetic stimulation and 
parasympathetic inhibition (Esler, 2000). To a great extent, the current literature about HRV 
indicate that the vagal modulation of the HR is compromised in patients with hypertension 
(Clifford, 2002; Esler, 2000; Esler, 2009; Kamath et al., 2012).  
 HRV can provide important prognostic information in patients with hypertension. A 
number of studies investigated the prognostic importance of HRV in predicting the future risk of 
developing hypertension (Chakko et al., 1993; Esler, 2000; Kamath et al., 2012; Schroeder et al., 
2003; Terathongkum & Pickler, 2004). The Atherosclerosis Risk in Communities study with a 
sample size of 12,000 showed that the HF ms2 and SDNN were negatively correlated with incident 
hypertension after a 3-year follow-up period (Liao et al., 1996). In addition, those with the highest 
hypertension had lowest HF ms2 and SDNN and highest LF/HF (Liao et al., 1996). Moreover, the 
second trial of the same project showed a negative correlation between the SDNN, RMSSD and 
the incident hypertension risk in the subjects followed for 9 years (Schroeder et al., 2003). Similar 
studies have further shown that patients with compromised ANS are at a high risk of developing 
hypertension. This is in line with the neural alterations (accentuated sympathetic and decreased 
parasympathetic activities) characterized with the early stages of hypertension (Julius, 1998; 
Kamath et al., 2012; Maver & Štrucl, 2004; Singh et al., 1998).  
 Antihypertensive medications, however, may be confounding factors in HRV analysis in 
patients with hypertension. It has been observed that patients with hypertension who use either β-
blockers (Greenwood et al., 2000; Kamath et al., 2012), angiotensin-converting enzyme inhibitors 
(Binkley et al., 1993) or diuretics (Tsuji et al., 1996) had decreased HRV. However, the overall 
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impacts of single or particular combinations of antihypertensive medications on HRV in patients 
with hypertension are still debatable (Kamath et al., 2012).    
2.3. HRV Signal Assessment 
The HRV signal is usually measured by ECG recording detected over a certain period of time 
(McCraty, 2015; Peltola, 2012; Shaffer et al., 2014). HR monitors are also used for measuring 
HRV and many of those, including the most recent version Polar V800TM, have been validated 
(Caminal et al., 2018; Giles et al., 2017; Giles et al., 2016). The algorithms of Polar HR monitors 
scan the raw data and identifies particular patterns of data such as the R-wave in the ECG signal 
(Nabil & Reguig, 2015). As the first R-peak is captured, the algorithm generates the time between 
this and the subsequent R-waves, which is called R-R intervals that are used to calculate HRV 
measures (Nabil & Reguig, 2015). This process of calculating R-R intervals repeats until the 
recording finishes.  
 The R-wave of QRS complex is utilized mostly as the fiducial point because of its distinct 
amplitude (De Geus et al., 2019; McCraty, 2015; Nabil & Reguig, 2015; Peltola et al., 2008; 
Shaffer et al., 2014). However, the true marker of the sinus rhythm is considered the P-wave, as 
the P-wave is the closest indicator of atrial depolarization than the R-wave on ECG (De Geus et 
al., 2019; McCraty, 2015; Nabil & Reguig, 2015; Peltola et al., 2008; Shaffer et al., 2014). In 
practice, the P-wave is too small to accurately detect it by the computer algorithms, particularly in 
the presence of artifacts though in theory, it would be more appropriate to utilize P-P intervals for 
HRV analysis (De Geus et al., 2019; McCraty, 2015; Nabil & Reguig, 2015; Peltola et al., 2008; 
Shaffer et al., 2014). However, several lines of evidence have shown that changes in R-R intervals 
reflect the SA node rhythms with high accuracy (De Geus et al., 2019; McCraty, 2015; Nabil & 
Reguig, 2015; Peltola et al., 2008; Shaffer et al., 2014). Therefore, the accurate R-wave detection 
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is of crucial importance in the obtaining of the reliable HRV outcomes. In other words, the 
accuracy of the R-wave detection is correlated with the lower number of artifacts in R-R intervals, 
and thus, improved HRV analysis.    
The general order of obtaining the time series of the R-R interval formation is as follows: 
1) the difference between each sequential R-R intervals is calculated; and 2) length of the 
sequential R-R intervals are defined, forming the discrete time series of R-R intervals (Peltola, 
2012). The time series of the R-R intervals are not sampled at fixed intervals because of the varying 
differences in the length of the neighboring R-R intervals (Peltola, 2012). Not equidistantly 
sampled R-R intervals are problematic for frequency domain measures as the power spectral 
analysis requires equally spaced R-R intervals (Peltola, 2012). Several methods have been 
recommended to avoid this issue prior to the power spectral analysis. A detailed description of 
each methods can be found elsewhere (Nabil & Reguig, 2015; Peltola, 2012) as it is beyond the 
scope of this thesis.    
Another important factor for obtaining accurate HRV measures is the sampling rate of the 
data acquisition system (e.g., ECG, HR monitor). Higher sampling frequency ensures the better 
resolution of the R-R intervals (Peltola, 2012; Shaffer et al., 2014). Lower sampling frequency 
may generate inaccurate HRV measures if the overall variability is abnormally low such as in 
patients with heart failure (Sessa et al., 2018; Shaffer et al., 2014). The recommended sampling 
frequency is at least 500-1000 Hz (Peltola, 2012; Shaffer et al., 2014).    
In 1996, the task force of the European Society of Cardiology and the North American 
Society of Pacing and Electrophysiology reported three methods for HRV signal assessment: 1) 
time domain analysis; 2) frequency domain analysis or power spectral density analysis; and 3) 
non-linear analysis (Malik et al., 1996).   
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2.3.1. Time Domain Measures 
Time domain measures quantify the amount of HRV during the entire recording and are divided 
into statistical and geometric measures. Table 1 shows the most commonly reported statistical and 
geometric time domain measures as well as brief descriptions.  
 
Table 1. Statistical and geometric time domain measures   
 
2.3.1.1. Statistical Measures 
Calculations of statistical time domain measures are based on beat-to-beat changes, and thus, are 
considered sensitive to outliers and artifacts. Statistical time domain measures (Table 1) from 
different studies can be compared with one another provided that the recording time is identical, 
and the data are obtained under the similar laboratory conditions (Heathers, 2014; Maud & Foster, 
2006; Shaffer et al., 2014). 
The SDNN reflects all regular or periodic fluctuations that contribute to the HRV, including 
the slow oscillations that reflect the intrinsic ability of the heart react to hormonal stimulants 
(Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). The SDNN is correlated with VLF, 
LF, and total power (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). The actual values 
of SDNN change depending on the recording length; when the recording is longer, then the SDNN 
Variables Units Description 
SDNN ms Standard deviation of normal R-R intervals 
RMSSD ms Root mean square of successive differences normal R-R intervals 
pNN50 % Percentage of successive normal R-R intervals greater than 50 ms 
HRV triangular 
index 
- Integral of the density of the R-R interval histogram divided by 
its height  
TINN ms Triangular interpolation of R-R intervals 
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values become higher and vice versa (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). 
Therefore, SDNN measures acquired from different recording lengths should not be compared 
with each other (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). Further, it is 
considered that SDNN is more accurate when analyzed over longer recordings (24 hr) than shorter 
recordings (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). 
The RMSSD measures the high frequency variations of the HR and reflects the 
parasympathetic influence on the heart (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 
2014). The RMSSD is strongly correlated with pNN50%, HF ms2, and SD1 (Heathers, 2014; Maud 
& Foster, 2006; Shaffer et al., 2014). While the RMSSD is less influenced by respiration than is 
respiratory sinus arrhythmia, the RMSSD is more influenced by the parasympathetic activity than 
the SDNN in general (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014).   
The pNN50% is strongly correlated with RMSDD and HF ms2, reflecting the influence of 
parasympathetic activity (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). However, 
most researchers prefer to report RMSSD over pNN50% in the time domain measures because it 
is thought that RMSSD provides better assessment of the respiratory sinus arrhythmia (Heathers, 
2014; Maud & Foster, 2006; Shaffer et al., 2014).  
2.3.1.2. Geometric Measures 
The basis of the geometric measures is a histogram of the frequency distribution. When the 
frequency distribution appears tight and high, it means that all R-R intervals remain within a small 
range of values, and thus HRV is low (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). 
However, when the frequency distribution appears wide and low, it means that R-R intervals 
remain within a large range of values, and thus HRV is high. Geometric time domain measures 
(Table 1) quantify the shape of the histogram of the R-R tachogram, presenting R-R intervals in 
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geometric patterns (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). These measures 
are considered insensitive to outliers, and thus, are more likely to be free of artifacts and software 
errors in obtaining accurate R-R intervals (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 
2014). In addition, they are recommended to be used only for long-term (usually 24hr) recordings 
as the evidence indicates that they may underestimate overall HRV of short-term recordings 
(Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). Table 4 shows the most commonly 
reported geometric time domain measures as well as a brief description. 
The HRV index is a measure that captures the duration of the R-R intervals that acts as the 
x-axis and the number of each R-R interval that acts as the y-axis of the plot (Heathers, 2014; 
Maud & Foster, 2006; Shaffer et al., 2014). The HRV index is calculated by taking the integral of 
the density of the R-R interval histogram (i.e., total number of R-R intervals) and dividing it by its 
height. Since the results depend on the width of the frequency histogram bin, the width of this bin 
is recommended to be set to 1/128 or 7.8 ms (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 
2014).  
The TINN is the baseline width of the normal R-R interval histogram in ms that is assessed 
through triangular interpolation. The TINN and HRV index are correlated with SDNN since all 
three variables reflect the total variance of HRV (Heathers, 2014; Maud & Foster, 2006; Shaffer 
et al., 2014). 
2.3.2. Frequency Domain Analysis 
The power spectral analysis was established in 1981 by Akselrod et al. for the purpose of 
decomposing the HRV waveform into its component rhythms, each representing a specific 
physiological influence (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). This finding 
of breaking down HRV by power spectral analysis dominated HRV research throughout the 1980s 
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(Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). Power spectral analysis can be 
measured by fast Fourier transform model (non-parametric) or autoregressive model (parametric) 
(Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). While the non-parametric fast Fourier 
transform model is fast and straightforward, it may cause spectra with many spikes for short HRV 
recordings (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). Parametric autoregressive 
model, on the other hand, is smoother and more appropriate for short HRV recordings although it 
is complicated to establish the optimal autoregressive model order (Heathers, 2014; Maud & 
Foster, 2006; Shaffer et al., 2014). Regardless of the methods, the calculation of power spectral 
analysis assumes an equally spaced time base, unlike an N-N interval base with variation between 
beats (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). 
Unlike time domain measures, power spectral analysis allows to split the waveform, 
thereby revealing the contribution of the separate physiological regulatory mechanisms on HRV 
that act at specific frequencies (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). 
Frequency is the number of events occurring repeatedly per unit of time.  Its unit of measures is 
the Hz where 0.1 Hz indicates that an event repeats once per every 10 seconds (Heathers, 2014; 
Maud & Foster, 2006; Shaffer et al., 2014). Table 2 contains the most commonly reported 
statistical and geometric time domain measures as well as brief descriptions.    
Table 2. Frequency time domain measures 
Variables Units Range (Hz) Description 
VLF ms2 < 0.04 Reflects the circadian rhythms, thermoregulation, 
and peripheral vasomotor influences 
LF ms2 0.04-0.15 Reflects sympathetic and parasympathetic nervous 
systems as well as baroreceptors  
HF ms2 0.15-0.40 Reflects parasympathetic influence and fluctuations 
caused by respiration  
LF/HF - - Reflects the sympathovagal balance  
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VLF band requires at least 5 min of recording, but 24 hr recording is considered to be 
optimal. The reason for the recording requirement for VLF ms2 is that it represents overall activity 
of the various slow physiological fluctuations reported in Table 2 and thus, it cannot be accurately 
estimated with 5 min or less of recording time (Heathers, 2014; Maud & Foster, 2006; Shaffer et 
al., 2014).   
 LF band represents the physiological influences reported in Table 2. The PNS can produce 
oscillations down to 0.05 Hz, whereas the SNS does not oscillate until  >0.1 Hz. Slow respiration 
can produce HR oscillations that cross over into the LF ms2. Hence, respiration driven vagal 
influences can be part of the LF ms2 if respiration frequency is <8 breaths per minute or if a person 
sighs or takes a deep breath (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). 
 HF band represents the physiological influences reported in Table 2. Also, the HF band is 
called the respiratory band since it correlates with HR rhythms influenced by the respiratory sinus 
arrythmia (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). 
 LF/HF ratio represents the physiological influences reported in Table 2. Although it still a 
matter of debate a low and high LF/HF ratio is considered to reflect sympathetic and 
parasympathetic dominance, respectively. Changes in LF/HF ratio may be either because of an 
increased sympathetic tone or parasympathetic withdrawal (Heathers, 2014; Maud & Foster, 2006; 
Shaffer et al., 2014).    
2.3.3. Non-linear Analysis 
The requirement for the time and frequency domain measures is that R-R intervals should be 
stationary. Non-stationary data indicate sudden variations in R-R intervals, mostly seen as 
response to exercise, posture change, or pathology such as hypertension (Heathers, 2014; Maud & 
Foster, 2006; Shaffer et al., 2014).   
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 Abrupt changes frequently occur in the ANS activity due to a variety of physiological or 
environmental stimuli, indicating the complexity of the heart rhythms (Heathers, 2014; Maud & 
Foster, 2006; Shaffer et al., 2014). Non-linear measures are used to calculate the complexity of 
heart rhythm by using the Poincare plot, which is a scatter plot where each R-R interval is plotted 
against the next R-R interval (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). In this 
way, a graphical representation of cardiovascular rhythms is provided, appearing in an elliptical 
shape (Heathers, 2014; Maud & Foster, 2006; Shaffer et al., 2014). Table 3 shows the most 
commonly reported non-linear HRV measures and a brief description.  
 
Table 3. Non-linear measures 
 
2.4. Artifacts in R-R Intervals 
Ideally, R-R intervals should consist of sinus rhythms (i.e., normal R-R intervals) to acquire 
accurate and reliable time, frequency, and non-linear HRV measures. However, the R-R intervals 
obtained from HR monitors are rarely perfect. Indeed, Polar HR monitors including the S810TM 
series, RS800G3TM, and the RS800CXTM, and the recent version of Polar V800TM showed varying 
percent of artifact/error rates: Polar S810iTM (6.93%) in healthy adults (Vanderlei et al., 2008), 
S810TM (0.40%) in active healthy adults (Gamelin et al., 2006), S810TM (0.32%) (Kingsley et al., 
2005) in healthy adults, and the recent version of Polar V800 (0.08%) (Giles et al., 2016) and 
(0.10%) (Giles et al., 2017) in supine position; and the Polar V800TM (0.08% and 0.06%) in healthy 
Variables Units Description 
SD1 ms Reflects short-term variability and is correlated with RMSSD 
and HF ms2  
SD2 ms Reflects long-term variability and is correlated with LF ms2  
SD2/SD1 - Reflects the unpredictability of R-R interval time series and is 
correlated with LF/HF ratio.  
26 
 
adults in standing position (Giles et al., 2016; Giles et al., 2017). The presence of artifacts can 
considerably distort the HRV signal, and thus, result in erroneous generation of the HRV signal. 
Distorted R-R intervals can easily be distinguished as their length is many times larger or smaller 
than the sinus rhythm intervals (Nabil & Reguig, 2015). Artifacts in R-R intervals are classified 
by technical and physiological origins.  
Artifacts with technical origin can result from a variety of reasons. For example; muscle 
contractions nearby the heart, especially from chest and arm muscles can distort the R-R intervals 
because of the electrical activity created during patient motion (Nabil & Reguig, 2015). 
Additionally, loose contact between the skin and chest strap or electrodes or sweating during the 
recording can cause artifacts with technical origin (Nabil & Reguig, 2015). Moreover, detection 
algorithms may fail to correctly identify the R-waves, causing sudden variations in the HRV (Nabil 
& Reguig, 2015). Presence of wireless networks that can interfere the Bluetooth transmission of 
HR monitors during the recording can also produce artifacts with technical origin (Giles et al., 
2017).   
Artifacts with physiological origins appear when the usual electrical activity of the heart is 
impaired due to various reasons. Normal heart rhythms are the result of regular electrical impulses 
originating from SA node (Peltola et al., 2012). When the origin of electrical impulses derives 
from the outside of the SA node, irregular and abnormal beats are produced such as ectopic 
(premature) and atrial or ventricular fibrillation (Peltola et al., 2012). These beats originate from 
atria or ventricles rather than SA node. When the origin of abnormal beats is from atria it is termed 
pre-mature atrial contraction, while it is termed pre-mature ventricular contraction when the origin 
of the beat is the ventricles (Peltola et al., 2012). Ectopic beats introduce signal ambiguity as they 
cause preceding and successive R-R intervals to differ from each other (Nabil & Reguig, 2015). 
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The appearance of ectopic beats in the time series of R-R intervals is usually viewed as a short R-
R interval followed by a long R-R interval compared to sinus rhythm intervals or vice versa (Figure 
5 and 6) (Nabil & Reguig, 2015). Therefore, the presence of ectopic beats can introduce extensive 
source of error into HRV measures (Nabil & Reguig, 2015). Although vast majority of persons 
experience ectopic beats, patients with cardiovascular diseases (e.g., myocardial infarction) tend 
to have more frequent (90-95%) artifacts with physiological origin as this population is more 
vulnerable to premature ventricular and atrial contractions (Kamath and Fallen, 1995; Peltola et 
al., 2012). However, technical artifacts are commonly observed with HR monitors regardless of 
the type of population.  
Artifacts with physiological origins and technical origins can appear simultaneously in the 
time series of  R-R intervals. Therefore, it is difficult to distinguish artifacts with physiological 
origins from artifacts with technical origins (Giles et al., 2017); ectopic beats can look identical to 
the following artifact types, particularly as a T1, T2, T3, or T4, which are defined under 2.4.1 
Types of Artifacts in R-R intervals (Nabil & Reguig,2015; Giles et al., 2017). 
2.4.1. Types of Artifacts in R-R Intervals 
Initially, five types of artifact descriptions were developed by (Gamelin et al., 2006) that included 
T1 through T5. Later, two more artifact descriptions were added by (Giles et al., 2016) after using 
Polar V800TM HR monitor in healthy individuals that include T6a and T6b. The descriptions of all 
seven artifacts from T1 to T6b are present below (Giles et al., 2016):    
Single Interval of Discrepancy (T1): T1 is defined as a positive or negative single interval 
difference > 20 ms (Figure 3). Artifact T1 is undetectable without simultaneous ECG recording 
because these may be the result of changes in interval length (Figure 3). An example of the 
appearance of T1 in an R-R interval time series would be as follows:  
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      Time  R-R Intervals 
0. 946   0. 946  
1.911  0. 965  
2.834  0. 923     
3.986  1. 152 [T1] 
4.878  0. 892 
5.685  0. 807 
6.586  0. 901 
          .       . 
     .                       . 
          .       .  
 
Figure 3. Appearance of a T1 artifact on the R-R interval tachogram                                
  
 
Long interval and short interval (T2): T2 is defined as a long interval followed by a short interval 
while the two R-R intervals on either side were < 20 ms (Figure 4). An example of the appearance 
of T2 in R-R interval time series would be as follows:      
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               Time     R-R Intervals 
247.513   0. 750  
248.261 0. 748  
248.999 0. 738     
250.342 1. 343 [T2] 
250.485 0. 143        
251.226 0. 741 
251.952 0. 726 
     252.663 0.711 
     .                       . 
     .                       .  
     .       . 
 
Figure 4. Appearance of a T2 artifact on the R-R interval tachogram    
  
 
Short interval and long interval (T3): T3 is defined as a short interval followed by a long interval 
while the two R-R intervals on either side < 20 ms (Figure 5). An example of the appearance of 
T3 in R-R interval time series would be as follows:  
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             Time  R-R Intervals 
131.622   0. 725  
132.337 0. 715  
133.053 0. 716     
133.335 0. 282 [T3] 
134.391 1. 056        
135.116 0. 725 
135.830 0. 714 
     136.573 0. 743 
     .                       . 
     .                       . 
     .        . 
    
Figure 5. Appearance of a T3 artifact on the R-R interval tachogram    
  
 
Too few intervals detected (T4): This is considered T4 and defined as missed beats equivalent to 
two or three ECG R-R intervals (Figure 6). An example of the appearance of T4 in R-R interval 
time series would be as follows:  
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             Time     R-R Intervals 
24.245   0. 739  
25.021  0. 776  
25.795  0. 774     
28.091  2.296 [T4] 
28.865  0. 774        
29.643  0. 778 
30.403  0. 760 
     .                       . 
     .                       . 
     .       . 
  
Figure 6. Appearance of a T4 artifact on the R-R interval tachogram     
  
 
Too many intervals detected (T5): T5 is defined as extra short beat equivalent to one ECG R-R 
interval (Figure 7). An example of the appearance of T5 in R-R interval time series would be as 
follows:   
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              Time    R-R Intervals 
157.670    0. 665  
158.356  0. 686  
159.052  0. 696     
159.338  0. 286 [T5] 
159.649  0. 311        
160.379  0. 730 
161.274  0. 895 
162.213  0. 939 
     .                       . 
Figure 7. Appearance of a T5 artifact on the R-R interval tachogram    
  
  
Entirely missed beats (undetectable) (T6a): T6a is defined as entirely missed beats while there is 
no difference in the HR monitor time stamp. Artifact T6a is undetectable without simultaneously 
measured ECG recording (Figure 8). An example of the appearance of T6a in R-R interval time 
series would be as follows:   
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              Time     Difference   R-R Intervals 
134.041       0. 629     0. 629  
134.643       0. 602      0. 602     
135.298       0. 655      0. 655 
     .   .         .      [T6a] 
135.964       0. 666     0. 666 
136.625       0. 661      0. 661 
137.268       0. 643      0. 643 
     .                  .              . 
     .                  .           . 
          .  .            . 
 
Figure 8. Appearance of a T6a artifact on the R-R interval tachogram     
  
 
Entirely missed beats (detectable) (T6b): T6b is defined as entirely missed beat while there is no 
difference in the HR monitor time stamp. Artifact T6b is detectable without a simultaneously 
measured ECG recording because a larger than expected gap in the time stamp is present (Figure 
9). An example of the appearance of T6b in R-R interval time series would be as follows:   
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               Time    Difference   R-R Intervals    
55.840       1. 302       1. 302  
56.881       1. 041         1. 041     
57.884       1. 003      1. 003 
     .           .              .      [T6b] 
59.841       1. 957      0. 842 
60.698       0. 857      0. 857 
61.605       0. 907      0. 907 
     .                 .           . 
     .                 .            . 
          .            .            .  
 
Figure 9. Appearance of a T6b artifact on the R-R interval tachogram     
  
 
The current literature shows that the most common artifact type that was detected by the 
Polar S810iTM, S810TM, RS800CXTM, and V800TM was T4 (missed beats) with the ratio varying 
around 60-90% of the total number of errors in the supine and standing  positions (De Rezende et 
al., 2016; Gamelin et al., 2006; Giles et al., 2017; Giles et al., 2016; Kingsley et al., 2005; Vanderlei 
et al., 2008; Vasconcellos et al., 2015). Even a single artifact can dramatically change HRV 
measures, particularly frequency domain variables; a T4 artifact or and ectopic beat has been 
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shown to increase HF ms2 and LF ms2 approximately 3-fold in HRV recordings in supine position 
(Berntson & Stowell, 1998; Nabil & Reguig, 2015). In addition, technical and physiological 
artifacts have been shown to increase SDNN, RMSSD, and pNN50% by approximately 2-fold 
(Bruggemann et al., 1993; Nabil & Reguig, 2015). Therefore, artifacts create a serious problem 
for obtaining accurate HRV measures and significantly increase the chance of ANS 
misinterpretation in healthy and unhealthy populations. The presence of a higher number of 
artifacts in clinical populations than that of healthy individuals makes the adults with hypertension 
more vulnerable to ANS misinterpretation. Therefore, correction of artifacts with an appropriate 
method is essential to prevent potential misinterpretation of ANS that may result in incorrect 
diagnosis of adults with hypertension.  
2.4.2. Precautions for R-R Intervals Free of Artifacts 
The number of artifacts in R-R intervals can be minimized with a well-controlled laboratory 
environment and following standard procedures before, during, and following the HRV recording. 
In a well-controlled laboratory environment, the following precautions should be taken (Malik et 
al., 1996): 1) HRV measurement should be carried out at the same time of a day because of the 
circadian rhythm that naturally causes changes in autonomic balance such as the morning and 
evening; 2) avoiding too bright a light or noise; 3) maintaining optimum room temperature; and 4) 
preparing the skin (i.e., shaving hair on the chest if necessary) for electrode attachment. Pre-
measurement precautions include (Malik et al., 1996): 1) avoiding caffeine or smoking at least 48 
hr before the experiment; 2) avoiding the HRV measurement immediately after a meal (at least 2 
hr required); and 3) at least 5 min pre-measurement resting period for the subjects to adjust 
themselves to the new environment. During experiment measurement precautions include (Malik 
et al., 1996): 1) maintaining a comfortable measurement position (e.g., supine, sitting, or standing); 
36 
 
2) avoiding movement, talking, or sleeping; and 3) avoiding intentional controlling of breathing. 
Collecting the R-R intervals free of artifacts, however, can still be quite challenging in the case of 
uncooperative subjects or long-term HRV measurements (Malik et al., 1996). Regardless of the all 
precautions, recording of absolutely clean and artifact-free data is difficult. Thus, it is necessary to 
review the recording and carefully correct any artifacts before calculating HRV measures to ensure 
accurate and reliable data. 
2.5. Correction of R-R intervals with Artifacts 
As mentioned previously, artifacts can significantly distort time, frequency, and non-linear HRV 
measures, especially frequency domain measures. When artifacts are present, the first option 
should be to select artifact-free segments of the R-R interval time series (Peltola, 2012). Clean 
segments of the R-R interval time series, however, should include no less than 2.5 min to ensure 
the accurate calculation of power distribution within a frequency domain (Peltola, 2012). If the 
ratio of distorted R-R intervals is <10% (or N-N intervals ≥ 90%) the artifacts can be replaced by 
different correction methods before the calculation of HRV measures (Peltola, 2012). However, if 
the ratio of distorted R-R intervals is > 20%, rejection of entire recording may be necessary 
(Peltola, 2012). 
2.5.1. Manual Correction 
Artifact correction can be performed manually or automatically using various HRV software 
packages. The general consensus regarding the more accurate method for correcting artifacts is the 
MC with visual confirmation of the R-R intervals and the appropriate correction method.  The MC 
cannot be truly replaced with automatic correction software packages (Peltola, 2012). First, 
(Gamelin et al., 2006) developed the guideline of methods of correction for T1 through T5. Later, 
(Giles et al., 2016) updated it by adding T6a and T6b after their validation of the Polar V800TM 
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HR monitor among healthy individuals. Previously, Gamelin et al., (2006 and Gamelin et al., 
(2008) corrected all artifacts from T1 to T5. However, (Giles et al., 2016) argued that correction 
of T1, a difference of 20 ms at a single interval (<50% increase in length over the adjacent 
intervals) could be either the result of an actual artifact or random fluctuation in interval length.  
Therefore, the detection of a T1 artifact would be impossible without the simultaneously recorded 
ECG. Similarly, Giles et al., (2016) concluded that T6a cannot be visible without simultaneous 
ECG recording as there seems to be no change in the HR monitor time stamp or R-R intervals 
when visually checked. Therefore, only identifiable artifacts (T2-T5, T6b) are recommended to be 
corrected following the guidelines below (Giles et al., 2016):  
Long interval and short interval: T2 is corrected by averaging the long and short intervals and the 
result is replaced with both intervals (Figure 4a). An example of a T2 correction artifact is as 
follows: 1.343 (long interval) + 0.143 (short interval) / 2 = 0.743.   
             Time        R-R Intervals      Correction  
247.513   0. 750       0. 750 
248.261 0. 748       0. 748 
248.999 0. 738         0. 738  
250.342 1. 343 [T2]          0. 743         
250.485 0. 143                  0. 743       
251.226 0. 741                  0. 741 
251.952 0. 726                  0. 726 
    252.663 0. 711                  0. 711 
     .                       .                         . 
     .                       .         . 
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Figure 4a. Correction of a T2 artifact on the R-R interval tachogram    
 
 
Short interval and long interval: T3 is corrected by averaging the short and long intervals and the 
result is replaced with both intervals (Figure 5a). An example of a T3 correction is as follows: 
0.282 (short interval) + 1.056 (long interval) / 2 = 0.669.   
           Time       R-R Intervals     Correction 
131.622   0. 725     0. 725 
132.337 0. 715     0. 715 
133.053 0. 716       0. 716 
133.335 0. 282 [T3]        0. 669 
134.391 1. 056                0. 669 
135.116 0. 725     0. 725 
135.830 0. 714    0. 714 
    136.573 0. 743    0. 743 
     .                       .        . 
     .                       .        . 
         .       .         . 
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Figure 5a. Correction of a T3 artifact on the R-R interval tachogram    
 
 
Too few intervals detected: T4 is corrected by dividing artificially long R-R interval by the number 
of missed beats and the result is replaced with the long interval however many missed beats are 
present (Figure 6a). An example of a T5 correction is as follows: 2.296 (artificially long R-R 
interval) / 3 (missed beats) = 0.765  
Time      R-R Intervals    Correction 
24.245   0. 739  0.739 
25.021  0. 776   0.776 
25.795  0. 774     0.744 
28.091  2.296 [T4] 0.765 
28.865  0. 774        0.765 
29.643  0. 778   0.765 
30.403  0. 760  0.774 
     .      .  0.778 
     .      .  0.760 
           .      .      . 
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Figure 6a. Correction of a T4 artifact on the R-R interval tachogram    
 
 
Too many intervals detected: T5 is corrected by adding two extra short R-R intervals together and 
the result is replaced with both intervals (Figure 7a). An example of a T5 correction is as follows: 
0.286 (extra short R-R interval) + 0.311 (extra short interval) = 0.597  
 Time        R-R Intervals Correction  
157.670    0. 665      0. 665 
158.356  0. 686      0. 686 
159.052  0. 696         0. 696  
159.338  0. 286 [T5]     0. 597 
159.649  0. 311            0. 730  
160.379  0. 730      0. 895 
161.274  0. 895      0. 939 
162.213  0. 939          . 
      .                       .          . 
      .                       .          . 
      .        .           . 
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Figure 7a. Correction of a T5 artifact on the R-R interval tachogram    
 
 
Entirely missed beats (detectable): T6b is corrected by subtracting the known interval from the 
difference in the time stamp, and the result is replaced with the entirely missed R-R interval and 
the known interval (Figure 9a). An example of a T6b correction is as follows: 1.957 (difference in 
the time stamp) – 0.842 (the known interval) = 1.115  
                        Time    Difference   R-R Intervals   Correction 
55.840       1. 302       1. 302           1. 302 
56.881       1. 041         1. 041       1. 041     
57.884       1. 003      1. 003      1. 003 
     .           .              .      [T6b]      1. 115 
59.841       1. 957      0. 842      1. 115 
60.698       0. 857      0. 857      0. 857 
61.605       0. 907      0. 907      0. 907  
     .                 .           .           . 
     .                 .            .           . 
         .            .            .            .  
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Figure 9a. Correction of a T6b artifact on the R-R interval tachogram    
 
 
2.5.2. Additional Manual Correction Methods 
Other manual correction methods are available in the current literature including deletion, degree 
zero, degree one, and cubic spline interpolations (Nabil & Reguig, 2015; Peltola, 2012) 
Interpolation methods (degree zero, degree one, cubic, cubic spline) can be performed using 
programming languages comprising MATLAB, Phyton, SciLab, etc.  A brief description of these 
methods and their impact on HRV measures are discussed below.    
In the deletion method, the distorted R-R intervals are eliminated, and previous normal R-
R intervals are moved to take place of the deleted R-R intervals (Nabil & Reguig, 2015; Peltola, 
2012). However, deletion of R-R intervals shortens the length of R-R interval time series, which 
can lead to an unacceptable bias in HRV measures, particularly with LF ms2 and HF ms2 (Nabil & 
Reguig, 2015; Peltola, 2012). Unlike the deletion, distorted R-R intervals are replaced with normal 
R-R intervals in the interpolation methods (Nabil & Reguig, 2015; Peltola, 2012). In these 
methods, therefore, the length of the R-R interval time series remains the same, reducing the 
chance of bias in HRV measures (Nabil & Reguig, 2015; Peltola, 2012). In the interpolation of 
degree zero method, artifacts are replaced with an average R-R interval that is calculated from 
adjacent R-R intervals (Nabil & Reguig, 2015; Peltola, 2012). When used on large sections of 
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artifacts, the degree zero causes a flat shape on R-R interval tachogram, an inaccurate trend, and 
significant biases in LF ms2 and VLF ms2 as the method calculates the same averaged R-R interval 
over a whole segment (Nabil & Reguig, 2015; Peltola, 2012). In the linear interpolation method, 
a straight line is placed over the artifacts to acquire new R-R intervals (Nabil & Reguig, 2015; 
Peltola, 2012). Similarly, with the degree zero method, when this method is used on large sections 
of artifacts, it results in slope-like shapes on the R-R interval tachogram (Nabil & Reguig, 2015; 
Peltola, 2012). This causes false trends and biases in LF ms2 and VLF ms2 (Nabil & Reguig, 2015; 
Peltola, 2012). The cubic interpolation uses four data points to calculate the polynomial (Nabil & 
Reguig, 2015; Peltola, 2012).  This method is considered a  non-linear analysis, examining the 
complexity and irregularity of R-R interval time series (Nabil & Reguig, 2015; Peltola, 2012). 
Therefore, the presence of a falsely correlated signal may cause problems in obtaining accurate 
HR measures, especially if there is high number of artifacts, while it does not result in flat section 
in R-R interval tachogram (Nabil & Reguig, 2015; Peltola, 2012). Finally, in the cubic spline 
interpolation, corrected values are calculated using numerous data points by placing a third-degree 
polynomial (Nabil & Reguig, 2015; Peltola, 2012). Similarly, as with cubic interpolation, spline 
interpolation may cause biases in the R-R interval time series if the number of artifacts is high 
(Nabil & Reguig, 2015; Peltola, 2012). Technical details of these correction methods can be found 
in (Nabil & Reguig, 2015) study.   
Giles et al., (2017) assessed the accuracy of deletion, interpolation methods, and Kubios 
(ver 2.2) in healthy individuals during incremental exercise with intensities varying from <40% to 
80-100% of VO2max. They found that degree one (linear interpolation) resulted in the smallest bias 
and effect size (ES) in majority of HRV measures compared to deletion, interpolation methods, 
and Kubios HRV (ver 2.2). However, they reported that biases and ESs at exercise intensities > 
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60% of VO2max were large for RMSSD, LF/HF ratio, SD1, and Sample Entropy despite of 
correction methods. Nevertheless, a consensus regarding the best manual correction method is still 
lacking in the current literature while most studies agree that deletion should not be used for artifact 
correction.  
2.5.3. Automatic Correction 
While the MC is more reliable method than automatic correction of artifacts, manual correction is 
tedious and requires a long time of careful R-R interval editing and certain level of expertise. For 
this reason, various HRV software packages with automatic correction options were developed to 
conveniently edit R-R intervals, which may perform sufficiently in healthy adults with small 
number of artifacts (Peltola et al., 2012).    
These software packages are not only used for automatically correcting artifacts but also 
for calculating HRV measures derived from R-R intervals. Some of the software packages are 
device-independent suggesting that they are not bundled with ECGs and HR monitors and that R-
R intervals are downloaded from both devices and uploaded to the software to calculate the HRV 
measures. Thus, correction of artifacts from both devices can either be performed manually 
independent of the software or automatically with the software, but the calculation of HRV 
measures derived from manually or automatically corrected R-R intervals of ECG and HR monitor 
are carried out with the same software. Other software packages are device-dependent indicating 
that they come bundled with ECGs (e.g., CardioPerfect WorkStation) and HR monitors (e.g., Polar 
ProTrainer 5TM) and that artifacts can only be automatically corrected and HRV measures derived 
from automatically corrected R-R intervals of ECG and HR monitor are calculated separately by 
each devices’ individual software package.   
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The most used HRV software package for editing artifacts is Kubios HRV (The Biomedical 
Signals Analysis and Medical Imaging Group, University of Kuopio, Finland) with citations in 
about 1000 studies (Kubios HRV [ver. 3.2] User’s Guide, 2019). Kubios started producing 
commercial (Premium) as well as free (Standard) software packages since January 2017. The 
commercial version began with Kubios HRV 3.0 and it was updated in January 2019 with Kubios 
HRV 3.2, which can be reached at the following reference (Kubios HRV [ver. 3.2] User’s Guide, 
2019). While the Standard version is primarily designed for non-commercial research and personal 
use, the Premium version is produced for researchers. Unlike the Standard, the Premium version 
calculates all time, frequency, and non-linear measures in addition to presenting time varying 
analysis. The Premium version also supports a broad range of ECG and HR in addition to 
photoplethysmogram data, whereas the Standard version supports only the data from HR monitors. 
The further details of the differences between Standard and Premium versions of Kubios HRV 3.2 
are present in the following reference (Kubios HRV [ver. 3.2] User’s Guide, 2019).  
 Kubios integrates visualizations of the R-R interval time series (i.e., tachogram) via a 
graphical interface and offers two artifact correction options including 1) AC; and 2) TBC. The 
AC option is available only in Kubios HRV Premium. The AC contains a robust algorithm for 
detecting artifacts with technical and physiological origins, which was validated by comparing it 
to Massachusetts Institute of Technology-Beth Israel Hospital arrhythmia database, demonstrating 
97% and 99.9% of successes in correctly detecting artifacts and normal beats, respectively (86, 
87). The technical details of the AC algorithm for detecting and correction artifacts are presented 
in the following reference (Kubios HRV [ver. 3.2] User’s Guide, 2019).  
The TBC detects and corrects the artifacts if they are outside of the thresholds including 
very low (0.45 sec), low (0.35 sec), medium (0.25 sec), strong (0.15 sec), and very strong (0.05 
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sec) compared to a local R-R interval average. The correction threshold can also be customized if 
the magnitude of difference does not include these thresholds. Each subjects’ data should be 
individually treated when using the TBC due to the high inter-individual variations observed in 
HRV data. Thus, using the same threshold for every subject can overcorrect the R-R intervals, and 
consequently, introduce considerable bias into HRV measures. In addition, the lowest correction 
method should always be a priority when using the TBC method to prevent potential 
overcorrections of normal R-R intervals (Kubios HRV [ver. 3.2] User’s Guide, 2019).  
 Figure 10 shows the R-R intervals with artifacts including: A) T3 at 00.00.05; and B) T4 
at 00.00.15 and T5 at 00.00.27. Corrections of these artifacts can be applied using the AC or TBC 
methods under the RR Interval Time Series Options of the user interface. Whether or not a 
correction method affects normal R-R intervals can be seen by checking the plot on the R-R data 
axis, showing the total number and percent of artifacts. Plotted artifacts are replaced with R-R 
intervals created by the cubic spline interpolation. In addition to automatic artifact correction, 
Kubios offers a manual correction option if ECG data are available. Artifacts can be corrected by 
fixing the falsely detected R-waves: all R-waves on the R-R tachogram are marked with a “+” sign 
(Figure 11). The falsely plotted signs can be adjusted by right clicking and selecting “Move”. If 
moving the signs does not correct the artifact, then it can be removed by right clicking and selecting 
“Remove” or a new sign (R-peak) can be added by right clicking and selecting “Add”. The details 
of the data pre-processing can be found in the following reference (Kubios HRV [ver. 3.2] User’s 
Guide, 2019). 
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Figure 10. Visual demonstration of Kubios HRV Premium (ver 3.2) corrections of T3, T4, and T5 artifacts on the R-R tachogram 
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Figure 11. Visual demonstration of a falsely detected R-wave and its manual correction 
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2.6. Validation of HRV Monitors 
Accuracy of HR monitors including the Polar S810TM (Gamelin et al., 2006; Gamelin et al., 2008; 
Kingsley et al., 2005), Polar S810iTM (Vanderlei et al., 2008), RS800G3TM (De Rezende Barbosa et 
al., 2016) , RS800CXTM (Vasconcellos et al., 2015), and V800TM (Giles et al., 2016)  have been 
compared to the gold standard ECG with 12-lead, 5-lead, 3-lead, and 2-lead in the supine and 
standing positions as well as during exercise (Caminal et al., 2018; Giles et al., 2017). However, 
these studies seem to have produced different results depending on the HR monitor, study setting, 
artifact correction methods, software package for HRV analysis, and subject characteristics (e.g., 
age, body mass index [BMI], gender, VO2max). Further, the most obvious difference between the 
studies was the number of HRV measures, particularly the absence of reporting non-linear 
measures. 
 Error rate in total number of R-R intervals varied depending on HR monitor model. In the 
supine position, it appears that the latest version of Polar HR monitor V800TM produced the lowest 
error rate. For example; Giles et al., (2016) and Giles et al., (2017) that validated Polar V800TM 
reported error rates of 0.08% and 0.10% among healthy individuals, whereas Kingsley et al., (2005), 
Gamelin et al., (2006), and Vanderlei et al., (2008) who examined the validity of Polar S810TM 
showed error rates of 0.32%, 0.40%, and 6.93% among healthy individuals (Board et al., 2016). 
Also, it has been shown that Polar V800TM produced error rates proportional to the exercise 
intensity among healthy individuals, which could be the result of increased chest movement during 
exercise. Gamelin et al., (2017) who validated the Polar V800TM among 18 healthy individuals 
during exercise performed under four intensities (<40%, 40-60%, 60-80%, 80%-100% of VO2max) 
reported error rates of 0.90% at <40% of VO2max, 2.25% at 40-60% of VO2max, 3.29% at 60-80% of 
VO2max, and 4.46% at 80-100% of VO2max. In addition, Caminal et al., (2018) that validated Polar 
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V800TM among 22 healthy individuals during a running of six mountain routes reported an error 
rate of 0.71%, which is expectedly higher than those reported at rest.  
 Current literature of validations studies show that using an identical correction method for 
pre-processing (i.e., detection of R-R intervals and correction of artifacts) and software package for 
subsequent HRV analyses improves agreeability and interchangeability of the R-R intervals and 
HRV measures between HR monitors and simultaneously recorded ECGs.  
 Agreeability between the corrected R-R intervals of Polar V800TM, RS800CX™, and 
S810™ HR monitors and ECGs were high in the supine position. For example; (Giles et al., 2016) 
showed bias (i.e., mean difference between two methods of measurement) of 0.06 and limits of 
agreement (LoA [i.e., the mean bias ± 1.96 x SD, the total error between two method of 
measurement]) ranges of -4.33 to + 4.45 ms between the corrected R-R intervals of Polar V800™ 
and the ECG among 20 healthy individuals (Board et al., 2016). Similarly, Vasconcellos et al., 
(2015) demonstrated bias of -10 and LoA ranges of -51.1 to 31.0 ms among 15 adolescents with 
obesity; and Montano et al., (2016) reported bias of +10 and LoA ranges of 8.0 to 12.0 ms between 
the corrected R-R intervals of Polar RS800CX™ and the ECG among 20 healthy individuals (Board 
et al., 2016). Additionally, between the corrected R-R intervals of Polar S810™ and the ECG, 
(Kingsley et al., 2005) reported bias of -0.06 and LoA ranges of -3.04 to +3.04 ms among 8 healthy 
individuals; Gamelin et al., (2006) showed bias of 0.9 and LoA ranges of -11.0 to +13.0 ms among 
healthy and physically active individuals; and Porto et al., (2009) reported bias of -1.85 and LoA 
ranges of -6.37 to 2.67 ms among 25 healthy and 8 individuals with obesity (n=2), emotional 
exhaustion (n=1), mitral valve prolapse (n=2), bicuspid aortic valve stenosis (n=1), Chagas’ disease 
(n=1), and Asthma (n=1) (Board et al., 2016).   
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 Agreeability of the R-R intervals between Polar V800TM and S810TM HR monitors and 
ECGs were also high in the standing position. In the standing position, Giles et al., (2016) reported 
bias of 0.59 and LoA ranges of -1.70 to +2.87 ms between the corrected R-R intervals of Polar 
V800™ and the ECG among healthy individuals. Moreover, between the corrected R-R intervals 
of Polar S810TM and the ECG, (Gamelin et al., 2006) showed bias of -0.70 and LoA ranges of -3.89 
to 2.50 ms among healthy and physically active individuals and Porto et al., (2009) reported bias of 
1.0 and LoA ranges of -6.0 to 8.5 ms among healthy and clinical populations (Board et al., 2016).  
 While Giles et al., (2017) did not report bias and LoA information of R-R intervals, Caminal 
et al., (2018) showed bias of <1 ms and LoA ranges of -3.55 to +3.57 ms among health individuals 
during exercise. (Kingsley et al., 2005) validated the Polar S810TM during exercise performed under 
the same exercise intensities as those reported by Giles et al., (2017). They did not report biases for 
varying exercise intensities but showed that the agreeability decreased as the exercise intensity 
increased with LoA ranges varying from -6.79 to 6.75 ms at <40% to -9.16 to 9.10 ms at 80-100% 
of VO2max (Board et al., 2016).  
 Furthermore, interchangeability between the corrected R-R intervals of Polar V800TM, 
RS800CX™, and S810™ HR monitors and ECGs was excellent in the supine position. For 
instance, it has been shown that intra-class correlations [(ICCs), defined as poor when ICC<0.50, 
moderate when ICC was between >0.50 and <0.75, good when ICC was between >0.75 and <0.90, 
and excellent when ICC was >0.90 (Koo & Li, 2016)], were 1.00 for Polar V800TM (Giles & Draper, 
2018; Giles et al., 2016), 0.98 (Vasconcellos at al., 2015) and 0.99 (Montano et al., 2016) for 
RS800CX™ , and 0.99 (Gamelin et al., 2006) and 1.00 (Kingsley et al., 2005) for S810™ (Board 
et al., 2016). Moreover, in the standing position, it has been demonstrated that ICCs were 1.00 for 
V800TM (Giles et al., 2017; Giles et al., 2016) and 0.99 for S810TM (Gamelin et al., 2006), indicating 
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an excellent interchangeability between the HR monitors and ECGs (Board et al., 2016). While 
Caminal et al., (2018) and Giles et al., 2017) did not report ICCs during exercise, Kingsley et al., 
(2005) showed that the interchangeability decreased as the exercise intensity increased with ICCs 
ranging from 1.00 at <40% to 0.93 at 80-100% of VO2max.   
 A good agreeability has been confirmed for all time, frequency, and non-linear measures 
with small biases and tight LoA ranges calculated from corrected R-R intervals recorded by Polar 
S810TM, RS800CXTM ,RS800G3TM and V800TM in supine position and standing position. However, 
RMSSD with a bias of -8.1 and LoA ranges of -10.4 to -5.8 ms, LFms2 with  bias of 28.0 and LoA 
ranges of 25.6 to 30.5 ms2, and HFms2 with  bias of -228.0 and LoA ranges of -230.7 to -225.4 ms 
(Montano et al., 2016); RMSSD with bias of 13.8 and LoA ranges of -18 to 45.6 ms, pNN50% with  
bias of 5.6 and LoA ranges of -15.0 to +26.2 %, LFnu with  bias of -7.5 and LoA ranges of -34.7 to 
+19.7, and HFnu with  bias of 7.6 and LoA ranges of -19.4 to +34.6 for Polar RS800CXTM 
(Vasconcellos at al., 2015); and LFms2 with bias of 36.3 and LoA ranges of -42.3 to +114.9 ms2 
and HF ms2 with bias of 27.3 and LoA ranges of -137.5 to 192.1 ms2 for Polar RS800G3TM (De 
Rezende Barbosa et al., 2016) showed that the agreeability was poor for these variables between 
the Polar RS800CXTM and RS800G3TM  HR monitors and ECGs in supine position.  
 Kingsley et al., (2005) that examined the validity of Polar S810TM during exercise bouts 
performed at <40%, 40-60%, 60-80%, and 80-100% of VO2max reported high agreeability for LF 
ms2 and HF ms2. However, Giles et al., (2017) that compared various correction methods including 
Kubios HRV (ver 2.2), deletion, linear interpolation, cubic interpolation, cubic spline interpolation, 
and degree zero during exercise bouts at the same intensities reported by Kingsley et al., (2005) 
showed poor agreeability for RMSSD, LF/HF, SD1, and Sample Entropy at exercise intensities > 
60% of VO2max. Also, Camelin et al., (2018) that validated Polar V800
TM among healthy individuals 
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who performed six mountain slopes reported a high agreeability with biases <1 and tight LoA 
ranges for all HRV measures.   
An excellent interchangeability has been confirmed for time, frequency and non-linear 
measures calculated form R-R intervals recorded by Polar V800TM and ECG with ICCs ranging 
from 0.98 and 1.00 for all other measures in supine and standing positions (Giles et al., 2016). On 
the contrary, Nunan et al., (2008) that examined the validity of Polar S810TM among 33 healthy 
individuals showed poor interchangeability for LF ms2 with an ICC of 0.70, HF ms2 with an ICC 
of 0.65, LF nu with an ICC of 0.51, HF nu with an ICC of 0.62, and LF/HF with an ICC of 0.76. 
Similarly, Vasconcellos et al., (2015) reported that Polar RS800CXTM produced poor 
interchangeability for pNN50% with an ICC of 0.47, LF nu with an ICC of 0.31, and HF nu with 
an ICC of 0.32. In addition, De Rezende et al., 2016 reported that Polar RS800G3TM resulted in 
poor interchangeability for LF nu and HF nu with ICCs of 0.74 for both variables (Board et al., 
2016). 
Giles et al., (2017) showed that Polar V800TM produced poor interchangeability for LF ms2 
with an ICC of 0.67 and HF ms2 with an ICC of 0.68 during an exercise bout performed at 40-60% 
of VO2max; VLF ms
2 with an ICC of 0.62, LF ms2 with ICC of 0.66, and LF/HF with an  ICC of 
0.56 during an exercise bout performed at 60-80% of VO2max; and HF ms
2 with an ICC of 0.51 
during an exercise bout performed at 80-100% of VO2max. Giles et al., (2017), however, reported 
an excellent agreement for all HRV measures during exercise bouts performed <60% of VO2max. 
Furthermore, Caminal et al., (2018) reported that Polar V800TM resulted in excellent 
interchangeability for all HRV measures. 
 The use of different correction methods for pre-processing of R-R intervals and software 
packages can increase the potential for errors. Calculating the HRV measures derived from 
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automatically corrected R-R intervals with separate device-dependent software packages results in 
incomparable HRV measures the supine position. For example; Wallen et al., (2012) performed 
correction of artifacts of the Polar RS800CXTM HR monitor and ECG and subsequent calculations 
of HRV measures with individual Polar Pro Trainer (ver. 5.0) and CardioPerfect software packages 
among a clinical population with varying level of emotional exhaustion. Although Wallen et al., 
(2012) confirmed the interchangeability for all HRV measures derived from Polar RS800CXTM in 
place of those derived from ECG for men with an ICC of 0.8, they did not confirm the 
interchangeability for women over 60 years with an ICC <0.75 on any HRV measures. In addition, 
it has been shown that the Polar RS800CXTM produced large biases and LoA ranges for all HRV 
measures, suggesting low agreeability between both devices among clinical populations (Wallen et 
al., 2012). Due to the low agreeability and interchangeability results between Polar HR monitors 
and ECGs, the Polar stopped providing device-dependent software packages since December 2015.  
 The current evidence indicates that accuracy of the Polar V800TM HR monitor improved 
compared to the previous versions of Polar S810TM and RS800CXTM. Also, generally high biases 
and LoA ranges and low ICCs of the Polar S810TM and RS800CXTM appear to result mainly from 
the use of device-dependent Polar software package for the calculation of HRV measures. 
Therefore, using an identical device independent HRV software package can prevent the potential 
bias into HRV measures derived from HR monitors in clinical populations such as patients with 
hypertension. Overall, HR monitors in sports and exercise settings show that SDNN, RMSSD, and 
LF/HF ratio consistently have good to excellent interchangeability with ECGs, but this information 
is lacking in clinical populations due to the scarcity of research in these individuals. 
 In conclusion, researchers and clinicians have become increasingly interested in using HR 
monitors due their convenience in measuring HRV, a biological marker that is strongly correlated 
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with compromised parasympathetic modulation, a common finding among individuals with 
hypertension. HRV measures, however, can be substantially distorted by artifacts with technical 
and physiological origins when using HR monitors that can lead to errors in interpreting the current 
status of hypertension. Therefore, if possible, the segment of R-R intervals free of artifacts should 
be selected as a first option. However, if that is not possible and the error rate of a sample >10% 
then artifacts should be corrected with a proper method. The MC is the most accurate and reliable 
method in correcting artifacts compared to the software packages offering automatic correction 
methods. The Polar Pro-trainer (ver.5), a device-dependent software package produce incomparable 
HRV measures among healthy and clinical populations due to the failure of correcting artifacts 
properly. Hence, Kubios HRV Premium (ver 3.2), a device-independent software package may be 
better in correcting artifact more accurately and thus produce comparable measures among healthy 
individuals at rest. Since the AC method was not available with the previous versions of Kubios 
HRV, the literature does not provide information as to which method of two can be chosen in 
correcting artifacts. Of note, however, if an error rate of a sample is >20% the data may result in 
inaccurate and unreliable HRV measures regardless of the correction methods. Additionally, 
deletion method should be used for correcting artifacts under any circumstances since it introduces 
substantial bias into HRV measures. Finally, improving the algorithms of HR monitors in detecting 
R-R intervals and the materials (e.g., the chest strap) may reduce the dependence on the artifact 
correction methods, which is what makes ECG the gold standard in measuring HRV.  
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CHAPTER 3: METHODS 
3.1. Study Overview 
All subjects attended one laboratory session between 6:00 and 11:00 am. Prior to the resting HRV 
measurement, subjects’ chests were cleaned for the ECG attachment and 12-lead ECG electrodes 
were placed on subjects. Later, the chest strap (H7) of Polar V800TM HR monitor was placed just 
below the pectoralis major muscles. Then, resting HRV was measured for 5 min in supine position 
following 5 min of resting period in the same position. Subjects were instructed to relax as much 
as possible but not sleep, move or talk. The R-R interval time series from ECG was stored in 
CASETM (ver 6.6) GE Healthcare system while those from Polar V800TM HR monitor was 
automatically stored in Polar Flow web service. Subjects completed an informed consent approved 
by the Institutional Review Boards of the University of Connecticut and Hartford Hospital. Subjects 
were recruited on rolling basis, beginning October 2016 until study completion in May 2018.  
3.2. Study Population 
Subjects were recruited from the surrounding community with direct mailings and posting of flyers, 
media advertisements, social media, previous studies, and from places of work and college 
campuses with the posting of flyers, listservs, class announcements, and newsletters.  Adults (n=25) 
with elevated (SBP ≥120-<130 mm Hg; DPB < 80 mm Hg) to established hypertension (SBP >130 
mm Hg; DBP >80 mm Hg) according to the updated American College of Cardiology/American 
Heart Association Guidelines for hypertension were enrolled (Arnett et al., 2019). Subjects who 
were being sedentary to regularly physically active (i.e., 150 min a week moderate or 75 min a 
week vigorous intensity exercise); were free of cardiovascular, pulmonary, renal, metabolic, or 
other chronic diseases and depression; did not smoke for at least 6 months prior to entry; and 
consumed less than two alcoholic drinks daily were included. Subjects with a medical history of 
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cancer-related lymphedema were excluded due to the risk of infection during HRV measurement. 
Moreover, subjects were excluded if they were trying to gain or lose weight because of the 
confounding effect of weight gain and loss on HRV (Karason et al., 1999). Furthermore, women 
who were pregnant, of planning to become pregnant, or were lactating were excluded (Stein et al., 
1999).   
3.3. Procedure 
Subjects were informed to consume a light breakfast 2-3 hours before and abstain from drinks 
containing alcohol and caffeine at least 48 hr before the testing.  BMI (kg.m-2) was measured from 
body weight and height collected with a calibrated balance beamscale, and waist circumference 
(WC) was measured using a Gullick tape at the narrowest part of the torso (Pescatello, 2013). 
Testing BP was measured following the standard American Heart Association procedures with an 
automated BPTRU monitor (BPTRU Medical Devices; Coquitlam, Canada). The measurements of 
BMI, WC, and BP preceded HRV recording that was performed in a supine position in a quiet, low-
light, and temperature-controlled room.   
Subjects’ chests were shaved if necessary. The ECG electrodes were placed in the Mason-
Likar configuration using the GE Stress System (CASE, Milwaukee, WI) (Papouchado et al., 1987).  
The ECG signal was checked to ensure that it was consistent and free of noise. After the signal was 
confirmed to be acceptable, the Polar V800TM H7 chest strap was fitted below the pectoralis major 
muscles and applied as described by the manufacturer. Subjects were placed in supine position for 
10 min, but the last 5 min of which was recorded for the analysis. During the recording, subjects 
were asked not to move, sleep or talk, and their breathing frequency was paced at 12 breaths/min–1 
using a metronome to control for the respiratory influences on HRV.  
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3.4. R-R Interval Recording 
The 12-lead ECG and Polar V800TM HR monitor with Polar H7 chest strap were started to 
simultaneously record R-R intervals at a sampling frequency of 1000 Hz. Cardiology XML files 
obtained from ECG were imported into Kubios HRV Premium (ver 3.2) (The Biomedical Signals 
Analysis and Medical Imaging Group, University of Kuopio, Finland) in order to export the R-R 
intervals detected automatically by its built-in QRS detection algorithm. Kubios HRV Premium 
(ver 3.2) marked each R-wave with “+” sign that can be moved or removed to correct falsely 
detected R-waves. The detected R-R intervals were manually inspected on the ECG tachogram to 
ensure that there were no false R-wave detections. If an R-wave was falsely determined, it was 
replaced by moving “+” signs on the correct R-wave. Then the detected R-R intervals from ECG 
were saved in a space delimited ASCII text file. In addition, the R-R intervals recorded by Polar 
V800TM HR monitor were exported from the Polar Flow web service (Version 2.3; Polar Electro 
Oy, Kempele, Finland) in a space delimited ASCII text file.  
3.4. Pre-processing of R-R Intervals 
3.4.1. Artifact identification 
First, the R-R intervals from ECG and Polar V800TM HR monitor in the space delimited ASCII text 
files were imported into the same spreadsheet side-by-side. Next the R-R intervals from both 
devices were synchronized by inserting 0 ms ensuring the comparison between the ECG and UN 
V800TM HR monitor R-R intervals. The technical artifacts (i.e., missed beasts) from the Polar 
V800TM HR monitor recordings or physiological artifacts (i.e., non-sinus beats) were then identified 
by comparing the R-R intervals from both devices. An artifact from the V800TM HR monitor was 
identified when the differences between ECG and Polar V800TM HR monitor R-R intervals were 
greater than 20 ms. Subsequently, the differences between the R-R intervals of ECG and Polar 
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V800TM HR monitor (i.e., type of artifacts) were assigned one of seven error types of the error 
identification and correction guideline developed by Gamelin et al., (2006) and Gamelin et al,m 
(2008) and recently updated by Giles et al., (2016). The updated version of the guideline contains 
extra two artifacts including T6-a and T6-b that were found with Polar V800TM HR monitor. The 
seven types of error are described under the heading of 2.4.1. Types of Artifacts in R-R Intervals in 
Chapter 2 (pg. 35-42). We followed the updated guidelines and reported all seven types of artifacts 
from T1 to T6b.   
3.4.2. Artifact Correction 
The artifacts were manually and automatically corrected after their identification. For the MC, non-
sinus beats in both signals (N=3) were replaced by interpolated R-R intervals from adjacent R-R 
intervals. Corrections were made only for T2, T3, T4, T5, and T6b since it is not possible to identify 
T1 and T6b artifacts without simultaneous ECG recordings.  Methods of correction for the errors 
are described under the heading of 2.5.1. Manual Correction in Chapter 2 (pg.45-50). 
The AC and TBC methods of Kubios HRV Premium (ver 3.2) were used to automatically 
correct the artifacts. It should be noted that the AC was not available in Kubios versions before the 
first commercial Kubios HRV Premium (ver 3.0) was released in January 2017. For the AC,  
“Automatic Correction” under “R-R Interval Series Option” was selected and then “ Apply” button 
was selected to correct the artifacts.  For the TBC, an appropriate threshold among very low (0.45 
sec), low (0.35 sec),  medium (0.25 sec), strong (0.15 sec), very strong (0.05 sec), and custom under 
“R-R Interval Series Option” was selected and then “Apply” button was selected to correct the 
artifacts. When the artifacts were corrected with the TBC, the lowest level of correction was chosen 
to prevent potential overcorrection. When artifacts were detected by both methods, they were 
automatically replaced through the cubic spline interpolation, a type of error correction. After the 
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artifact corrections were made, the R-R interval time series was then considered normal and defined 
as N-N intervals (Kubios HRV [ver. 3.2] User’s Guide, 2019).  
3.4.2. Calculation of HRV Measures 
Following the identification and correction of the artifacts, a corresponding segment of the N-N 
intervals with varying recording length in the ASCII text files from ECG and Polar V800TM HR 
monitor was selected for the calculation of the HRV measures. Commercial Kubios HRV Premium 
(ver 3.2) analyzed the selected segments to obtain the time, frequency, and non-linear domains of 
HRV measures.  
 The time domain measures quantify the amount of variability within the sample and they 
included SDNN, RMMSD, and pNN50%. Frequency domain measures show the contribution of 
SNS and PNS modulation within the sample they included LF ms2 HF ms2, LFnu, HFnu, and LF/HF 
ratio. Power spectral density analysis reveals the content of signal’s power (variance) versus 
frequency and can be analyzed by the autoregressive and fast Fourier transform methods (Shafer 
2017). A fast Fourier transformation was performed to quantify power spectrum density into the 
LF (0.04–0.15 Hz) and HF (0.15–0.40 Hz) frequency bands. In addition, normalized units of the 
LF and HF bands and LF/HF ratio were calculated. Non-linear domain measures represent the 
unpredictable heartbeat dynamics caused by the complex interactions between a number of 
regulatory systems and they included SD1, SD2, and SD2/SD1. The non-linear measures were 
analyzed as a Poincaré plot, a type of graph where each N-N interval is plotted against next N-N 
interval, making a scatter plot (Shafer et al., 2017). The analysis consisted of placing an ellipse to 
the plotted points (Shaffer et al., 2017). The SD of each plotted N-N interval from the y= x axis 
(SD1 or ellipse’s width), the SD of each plotted N-N interval from the y = x + average N-N interval 
(SD2 or ellipse’s length), and SD2/SD1 ratio were then calculated (Shafer et al., 2017).  
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3.5. Statistical Analysis 
The magnitude of difference between the R-R intervals and HRV measures from ECG and Polar 
V800TM HR monitor were calculated by measuring effect size (ES) as the mean difference over the 
standard deviation of the difference (Thomas et al., 2010). The ES was defined as trivial when ES 
<0.2, small when ES was between >0.2 and <0.5, moderate when ES between >0.5 and <0.8, and 
large when ≥0.8 (Cohen 2013). The ICC with the 95% confidence interval (CI) assessed the 
concurrent validity (or interchangeable agreement) of the R-R intervals and HRV measures 
(Atkinson & Nevill, 1998). The ICC was defined as poor when ICC<0.50, moderate when ICC was 
between >0.50 and <0.75, good when ICC was between >0.75 and <0.90, and excellent when ICC 
was >0.90 (Koo and Li, 2016). Bland-Altman plots were created for the ECG R-R intervals versus 
Polar V800TM HR monitor for the UN, AC, TBC, and MC R-R intervals. The 95% limits of 
agreement (LoA) for lower (-1.96) and upper limit (+1.96) were calculated as follows: 1) lower 
limit: mean difference - (SD of difference x 1.96); and 2) upper limit: (SD of difference x 1.96) + 
mean difference (Bland and Altman, 1986). Homoscedasticity and heteroscedasticity were 
inspected through a histogram and Q-Q plot. In the case that was detected in the heteroscedasticity 
in HRV measures, the data were logarithmically transformed before the calculation of LoA ranges. 
All statistical analyses were conducted using SPSS (Version 24; Chicago, IL, USA) 
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CHAPTER 4: RESULTS 
4.1. Subject Characteristics 
Participants were 17 men (68%) and 8 women (28%)  between 18 and 55 years of age who were 
overweight to obese with hypertension (Table 4). Of these, six subjects were taking 
antihypertension medication that included diuretics (n=1), angiotensin II receptor antagonists 
(n=3), and β-Blockers (n=2).   
 
Table 4. Subjects Characteristics (n=25, mean±SD) 
 
4.2. Agreeability and Interchangeability of R-R Intervals 
Table 5 presents the type, number, and percent of detected artifacts from the Polar V800TM HR 
monitor among the total number of artifacts in the supine position.  There were a total of 71 artifacts 
among 8325 total R-R intervals yielding an error rate of 0.85%, which was calculated by dividing 
the total number of artifacts by the total number or R-R intervals and multiplying the result by 100. 
The length of HRV measurement for eight subjects was less than 5 min due to the loss of connection 
between the HR monitor and the strap for unknown reasons. Therefore, the average length of the 
HRV measurement was 4.6±0.9 min and the number of R-R intervals was 333.0±70.5.   
Variable Results 
Age (year) 44.7±10.1 
Height (cm) 172.3±11.0 
Weight (kg) 93.7±30.6 
Body Mass Index (kg.m-2) 29.8±4.3 
Waist Circumference (cm) 99.9±12.1 
Heart Rate (bpm) 73.6±11.0 
Systolic Blood Pressure (mmHg) 132.3±12.2 
Diastolic Blood Pressure (mmHg) 84.3±10.2 
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Figure 13 contains the Bland-Altman plots of the level of agreement and interchangeability 
between the R-R intervals from the ECG and the UN, AC, TBC, and MC R-R intervals from the 
Polar V800TM HR monitor. The UN R-R intervals from the Polar V800TM HR monitor were 
corrected using the AC and TBC methods of Kubios Premium (ver 3.2) and MC. While the bias 
(0.69 ms) and ES (0.004) were small, the UN R-R intervals resulted in the widest range of LoA 
(from -215.80 to 214.42 ms) (Figure 12). The AC method using the Kubios HRV Premium (ver 
3.2) resulted in corrected R-R intervals with higher bias (3.79 ms), range of LoA (from -130.32 to 
137.90 ms), and ES (0.024) (Figure 13) than the bias (1.16 ms), range of LoA (from -92.67 to 94.98 
ms), and ES (0.008) of the TBC method (Figure 14). The MC method produced corrected R-R 
intervals with the smallest bias (0.37 ms), tightest range of LoA (-41.20 to 41.94 ms), and smallest 
effect size (0.002) (Figure 15). Furthermore, an improvement in the ICC of the UN R-R intervals 
occurred depending on the method of correction that was used.  The ICC of UN R-R intervals went 
from 0.79 (95 % CI 0.78-0.80) to 0.91 (95 % CI 0.90-0.91) in the AC R-R intervals, 0.95 (95% CI 
0.95-0.95) in the TBC R-R intervals, and 1.00 (95% CI 1.00-1.00) in MC R-R intervals. 
 
Table 5. Types of errors detected in the Polar V800TM HR monitor R-R intervals in supine position  
*Percent of detected errors is calculated as follows: (the number of a particular error/the total number artifacts) x 100. The 
total number of errors= 71.  
  
 
 
Type of Error Number of Detected Errors Percent of Detected Errors* 
T1 5  7.0% 
T2 1  1.4% 
T3 5  7.0% 
T4 49  69% 
T5 7 9.9% 
T6a 2 2.8% 
T6b 2  2.8% 
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          Figure 12. Bland-Altman plots for the ECG and the UN Polar V800TM HR monitor R-R intervals 
 
ECG: electrocardiogram; HR; heart rate; UN; uncorrected R-R intervals 
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         Figure 13. Bland-Altman plots for the ECG and the AC Polar V800TM HR monitor R-R intervals 
 
ECG: electrocardiogram; HR; heart rate; AC; R-R intervals corrected by automatic correction method of the Kubios 
HRV Premium (ver 3.2) 
 
 
 
 
 
 
 
 
-2000
-1500
-1000
-500
0
500
1000
1500
2000
0 500 1000 1500 2000
D
if
fe
re
n
ce
 b
et
w
ee
n
 E
C
G
 a
n
d
 A
C
 P
o
la
r 
V
8
0
0
T
M
R
-R
 I
n
te
rv
al
s 
(m
s)
Mean R-R Intervals (ms) 
- 1.96 SD
Mean
+ 1.96 SD
66 
 
 
           Figure 14. Bland-Altman plots for the ECG and the TBC Polar V800TM HR monitor R-R intervals 
 
ECG: electrocardiogram; HR; heart rate; AC; R-R intervals corrected by threshold-based correction method of the 
Kubios HRV Premium (ver 3.2)   
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          Figure 15. Bland-Altman plots for the ECG and the MC Polar V800TM HR monitor R-R intervals 
 
ECG: electrocardiogram; HR; heart rate; AC; R-R intervals corrected manually  
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4.3. Agreeability and Interchangeability of HRV Measures 
Table 6, 7, 8, and 9 contain the comparisons of the HRV measures calculated from UN, AC, TBC, 
and MC Polar V800TM HR monitor R-R intervals versus those calculated from ECG R-R intervals 
using the Kubios Premium (ver 3.2) software.    
The UN resulted in the largest biases and the widest LoA ranges for all HRV measures 
compared to the AC, TBC, and MC methods. The UN had ES ranging from 0.091 to 0.835 
indicating the magnitude of difference between the HRV measures calculated from UN Polar 
V800TM HR monitor and ECG R-R intervals was trivial to large and had 5 out of 11 HRV measures 
between 0.2≤ and <0.5, indicating moderate difference. Additionally, the UN had ICCs ranging 
from 0.070 to 0.98 suggesting poor to excellent interchangeable agreement but had 7 out of 11 
HRV measures below <0.5, indicating poor interchangeable agreement (Table 6). Between the two 
correction methods of Kubios HRV Premium (ver 3.2), the TBC resulted in smaller biases than 
the AC for SDNN, RMSSD, pNN50%, LFnu, HFnu, LF/HF ratio, SD1, SD2, and SD2/SD1, but 
the AC produced smaller biases than TBC for LFms2 and HFms2. Additionally, when the TBC 
was compared to the AC method, the TBC produced tighter LoA ranges and smaller ES (<0.031 
versus <0.085) for all HRV measures.  
Moreover, the TBC method exhibited ICCs varying from 0.96 to 1.00, while the AC had 
ICCs ranging from 0.79 to 0.99, indicating that the interchangeability slightly improved from 
good-to-excellent to excellent when the correction was made with the TBC (Table 7 and Table 8). 
Whereas the MC produced the smallest biases for SDNN, RMSSD, pNN50%, LF/HF, SD1, SD2, 
and SD2/SD compared to the AC and TBC methods, the MC caused larger biases for LFms2 and 
HFms2 than the AC and also for LFms2, LFnu, and HFnu than the TBC. Additionally, when the 
MC was compared to the AC and TBC methods, the MC resulted in the tightest LoA ranges and 
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smallest ES (<0.019) for all HRV measures. Furthermore, the MC had ICC of 1 for all HRV 
measures indicating excellent reliability for all HRV measures (Table 9).    
The possible impact of gender, medication use (particularly β-Blocker use), VO2max, BMI, 
and HRV measurement length was examined, but we found that they did not influence the biases, 
LoA ranges, ICCs, or ESs of the comparison of  the HRV measures calculated from the UN, AC, 
TBC, and MC Polar V800TM and ECG R-R intervals.  
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Table 6. Comparison of HRV measures calculated from UN Polar V800TM and ECG R-R intervals (mean ± SD)   
ECG: electrocardiogram; UN: uncorrected R-R intervals;  ICC: intra-correlation coefficient; LoA: limits of agreement; SDNN: standard deviation of normal-to-normal 
N-N intervals; RMSSD: root mean square of the successive difference of intervals; pNN50%: the percentage of successive normal cardiac inter-beat intervals greater than 
50 msec; LF: low frequency; HF: high frequency; SD: standard deviation. 
 
Table 7. Comparison of HRV measures calculated from Kubios Premium (ver 3.2) AC Polar V800TM and ECG R-R intervals (mean ± SD)   
AC: R-R intervals corrected by automatic correction method of Kubios HRV Premium (ver 3.2)  
HRV Measure ECG 
(mean±SD) 
Polar UN 
(mean±SD) 
Bias (LoA) ICC (95% CI) Effect Size  
SDNN (ms) 55.5±26.7 90.5±62.2 -34.95 (-143.58 to 73.69) 0.27 (-0.07-0.57) 0.730  
RMSSD (ms) 38.3±29.4 92.8±96.3 -57.51 (-223.81 to 114.78) 0.21 (-0.11-0.52) 0.765 
pNN50 (%) 13.6±16.2 15.1±15.9 -1.50 (-6.14 to 3.21) 0.98 (0.95-0.99) 0.091 
LF (ms2) 1215±1352.1 6924.2±16947.2 -5709.13 (-38536.30 to 27118.05) 0.53 (-0.97-0.57) 0.475 
HF (ms2) 740.8±1262.8 4861.0±6863.9 -4120.18 (-17136.40 to 8896.033) 0.07 (-0.21-0.39) 0.835 
LF (nu) 67.3±18.7 59.7±20.3 7.53 (-30.13 to 45.20) 0.49 (0.14-0.73) 0.387 
HF (nu) 32.7±18.6 40.2±20.2 -7.53 (-45.20 to 30.13) 0.49 (0.14-0.73) 0.387 
LF/HF Ratio 3.6±4.0 3.0±4.2 0.67 (-3.37 to 4.71) 0.87 (0.72-0.94) 0.163 
SD1 (ms) 27.1±20.8 65.7±68.2 -38.62 (-158.55 to 81.31) 0.21 (-0.11-0.52) 0.765 
SD2 (ms) 72.7±33.6 106.5±62.1 -33.80 (-137.14 to 69.53) 0.37 (-0.01-0.66) 0.677 
SD2/SD1 Ratio 3.4±1.4 2.7±1.6 0.66 (-1.45 to 2.76) 0.68 (0.32-0.85) 0.442 
HRV Measure ECG 
(mean±SD) 
Polar AC 
(mean±SD) 
Bias (LoA) ICC (95% CI) Effect Size 
SDNN (ms) 55.5±26.7 57.1±28.1 -1.60 (-23.27 to 20.06) 0.92 (0.83-0.96) 0.058  
RMSSD (ms) 38.3±29.4 36.2±25.4 2.13 (-25.57 to 29.84) 0.87 (0.73-0.94) 0.078  
pNN50 (%) 13.6±16.2 13.1±16.1 0.51 (-7.28 to 8.29) 0.97 (0.93-0.99) 0.031  
LF (ms2) 1215±1352.1 1214.2±1360.9 0.80 (-369.45 to 371.06) 0.99 (0.98-1.00) 0.001  
HF (ms2) 740.8±1262.8 749.1±1239.5 -8.27 (-1115.84 to 1099.293) 0.90 (0.79-0.96) 0.007 
LF (nu) 67.3±18.7 66.7±19.6 0.57 (-24.29 to 25.44) 0.79 (0.57-0.90) 0.030  
HF (nu) 32.7±18.6 33.3±19.6 -0.57 (-25.44 to 24.29) 0.79 (0.73-0.95) 0.030 
LF/HF Ratio 3.6±4.0 3.5±3.9 0.12 (-1.76 to 2.00) 0.97 (0.94-0.99) 0.031 
SD1 (ms) 27.1±20.8 25.6±18 1.51 (-18.12 to 21.14) 0.87 (0.73-0.94) 0.078 
SD2 (ms) 72.7±33.6 75.6±36.4 -2.97 (-26.11 to 20.17) 0.94 (0.87-0.97) 0.085 
SD2/SD1 Ratio 3.4±1.4 3.4±1.3 -0.07 (-1.01 to 0.87) 0.94 (0.86-0.97) 0.055 
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Table 8. Comparison of HRV measures calculated from Kubios Premium (ver 3.2) TBC Polar V800TM and ECG R-R intervals (mean ± SD)   
TBC: R-R intervals corrected by threshold-based correction method of Kubios HRV Premium (ver 3.2)  
 
 
Table 9. Comparison of HRV measures calculated from MC R-R intervals between the ECG and Polar (mean ± SD)   
MC: R-R intervals corrected manually 
HRV Measure ECG 
(mean±SD) 
Polar TBC 
(mean±SD) 
Bias (LoA) ICC (95% CI) Effect Size  
SDNN (ms) 55.5±26.7 56.1±27.6 -0.55 (-10.59 to 9.49) 0.98 (0.96-0.99) 0.020 
RMSSD (ms) 38.3±29.4 37.8±27.5 0.53 (-9.57 to 10.63) 0.98 (0.96-0.99) 0.019 
pNN50 (%) 13.6±16.2 13.8±16.2 -0.16 (-1.33 to 1.02) 0.99 (0.98-1.00) 0.010 
LF (ms2) 1215±1352.1 1209.2±1352.5 5.86 (-275.86 to 287.59) 1.00 (0.99-1.00) 0.004 
HF (ms2) 740.8±1262.8 703.7±1201.6 37.07 (-460.59 to 534.74) 0.98 (0.95-0.99) 0.030 
LF (nu) 67.3±18.7 67.3±18.0 -0.02 (-4.04 to 4.01) 0.99 (0.99-1.00) 0.001 
HF (nu) 32.7±18.6 32.7±18.0 0.02 (-4.01 to 4.04) 0.99 (0.99-1.00) 0.001 
LF/HF Ratio 3.6±4.0 3.5±3.9 0.12 (-0.79 to 1.02) 0.99 (0.98-1.00) 0.029 
SD1 (ms) 27.1±20.8 26.7±19.5 0.38 (-6.78 to 7.53) 0.98 (0.96-0.99) 0.019 
SD2 (ms) 72.7±33.6 73.8±35.7 -1.09 (-14.39 to 12.21) 0.98 (0.96-0.99) 0.031 
SD2/SD1 Ratio 3.4±1.4 3.3±1.4 0.03 (-0.74 to 0.80) 0.96 (0.91-0.98) 0.021 
HRV Measure ECG 
(mean±SD) 
Polar MC 
(mean±SD) 
Bias (LoA) ICC (95% CI) Effect Size  
SDNN (ms) 55.5±26.7 55.3±26.7 0.21 (-0.70 to 1.12) 1.00 (1.00-1.00) 0.009 
RMSSD (ms) 38.3±29.4 38.1±29.1 0.18 (-1.82 to 2.18) 1.00 (0.99-1.00) 0.006 
pNN50 (%) 13.6±16.2 13.7±16.1 -0.11 (-1.52 to 1.30) 1.00 (0.99-1.00) 0.007 
LF (ms2) 1215±1352.1 1208.2±1351 6.85 (-65.77 to 79.48) 1.00 (1.00-1.00) 0.005  
HF (ms2) 740.8±1262.8 730.9±1267.1 9.94 (-44.20 to 64.07) 1.00 (1.00-1.00) 0.008  
LF (nu) 67.3±18.7 67.6±18.6 -0.35 (-1.68 to 0.98) 1.00 (1.00-1.00) 0.019  
HF (nu) 32.7±18.6 32.3±18.6 0.35 (-0.98 to 1.68) 1.00 (1.00-1.00) 0.019  
LF/HF Ratio 3.6±4.0 3.7±4.0 -0.04 (-0.23 to 0.14) 1.00 (1.00-1.00) 0.011  
SD1 (ms) 27.1±20.8 27.0±20.6 0.13 (-1.29 to 1.54) 1.00 (1.00-1.00) 0.006  
SD2 (ms) 72.7±33.6 72.5±33.5 0.21 (-0.55 to 0.97) 1.00 (1.00-1.00) 0.006  
SD2/SD1 Ratio 3.4±1.4 3.4±1.4 0.01 (-0.14 to 0.15) 1.00 (1.00-1.00) 0.005  
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CHAPTER 5: DISCUSSION 
In the current study, we compared raw R-R intervals and HRV measures derived from the Polar 
V800TM HR monitor to the gold standard 12-lead ECG to determine their level of agreement and 
interchangeability among a sample of 17 men and 8 women with hypertension who were 
overweight to obese and of very poor to good cardiorespiratory fitness for men and women of their 
age. In addition, we sought to determine  the level of accuracy of the MC as well as AC and TBC 
methods of Kubios HRV Premium (ver 3.2) in correcting artifacts among this sample. The results 
demonstrate that Polar V800TM can provide R-R intervals consistent with the ECG and that HRV 
measures calculated from both devices are highly comparable in adults with hypertension in supine 
position as long as the raw R-R intervals are corrected.  
 The error rate in the current study (0.85%) was higher than those reported by Giles et al., 
(2016) (0.08%; -0.77%) and Giles et al., (2017) (0.10%; -0.75%) that validated the Polar V800TM 
among healthy adults (n=20 [3 F and 17 M]; n=18 [0 F and 18 M]) with normal BMI (18.5-24.9 
kg.m-2) in supine position. This suggests that the performance of the Polar V800TM in the detection 
of R-R intervals somewhat declined in adults with hypertension compared to healthy adults in 
supine position. The data acquisition and analyses methods were the same between our study and 
the studies of Giles et al., (2016) and Giles et al., (2017). However, the autonomic modulation of 
our subjects were substantially lower than those reported in both studies as evidenced by declined 
time domain measures (SDNN: 55.5 versus 61.4 [Giles et al., 2016] and 81.3 ms [Giles et al., 
2017]; RMSSD: 33.8 versus 55.9 and 75.9 ms; pNN50%: 13.6 % versus 29.1% and 38.9%), 
frequency domain measures (HF ms2: 740.8 versus 1827.0 [Giles et al., 2016]  and  3978.2 ms2 
[Giles et al., 2017]; LFnu: 67.3 versus 41.0 and 36.8; HFnu: 32.7 versus 59.0 and 63.1; LF/HF: 
3.6 versus 1.0 and 0.8), and non-linear domain measures (SD1: 27.1 versus 45.0 [Giles et al., 2016] 
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and 53.7 [Giles et al., 2017; SD2: 72.7 versus 84.0 and 100.9). Dysregulation/dysfunction of the 
ANS, a potential underlying mechanism for hypertension results in diminished R-wave amplitude 
(Baron et al., 1980), an important factor that can compromise the ability of HR monitors to 
accurately detect the R-R intervals that are used to calculate HRV measures. Therefore,  
hypertension may indirectly explain the higher error rate (i.e., higher number of distorted R-R 
intervals) observed in the current study. 
The most common type of error encountered in the Polar V800TM uncorrected R-R intervals 
was T4 (Table 2), which is in accordance with the previous studies reporting the percent of T4 
error varying between 60% and 90% of total number of errors (Gamelin et al., 2006; Giles et al,., 
2016; Giles et al., 2017). The T4 may be the result of a decrease in R-wave amplitude due to a loss 
or decrease in connection between the chest strap and skin (Giles et al., 2016). The second most 
commonly reported artifact in the Polar V800TM uncorrected R-R intervals was T5 with (Table 2). 
Gamelin et al., (2006) thought that additional contractions during a single systole lead to T5, 
causing HR monitors to misidentify the T-waves or/and P-waves as R-waves. Of note, the Polar 
V800TM uncorrected T1 and T6a errors can be seen on the corrected Bland–Altman plots (Figure 
15) as outliers, a similar finding reported by Giles et al., (2016).  Nevertheless, these errors cannot 
be easily seen in the R-R interval time series as opposed to T2, T3, T4, T5, and T6b errors.  
The MC was the most successful method of correction with the highest decrease in bias 
(0.69 to 0. 37 ms for the UN R-R and the MC), LoA ranges (-215.80 to 214.42 ms and -41.20 to 
41.94 ms for the UN R-R and the MC), and the highest increase in ICC (0.79 to 1.00 for the UN 
R-R and the MC) compared to the AC (bias: 3.79 ms, LoA ranges: -130.32 to 137.90 ms, and ICC: 
0.91) and TBC (bias: 1.16 ms, LoA ranges: -92.67 to 94.98 ms, and ICC: 0.95) methods.  The bias 
of the MC (0.37 ms) in this study, though somewhat larger, was consistent with Giles et al., (2016) 
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who reported bias of 0.06 between the Polar V800TM and ECG. However, LoA ranges of the MC 
(-41.20 to 41.94 ms) we found were considerably wider than those (-4.33 to +4.45 ms) reported 
by Giles et al (2016). Further, while the bias of Polar V800TM R-R intervals corrected by the MC 
was slightly lower than that of Polar S810TM R-R intervals corrected by the MC (0.90), the LoA 
ranges we found (-41.20 to 41.94 ms) were noticeably higher than those (-11.0 to +13.0 ms) 
reported by Gamelin et al., (2006). These results are consistent with the higher error rate in the 
total number of R-R intervals of the current study (0.85%) than those of reported by Giles et al 
(2016) (0.08%) and Gamelin et al., (2006) (0.40%), indicating that quality of R-R intervals may 
impact the precision of the MC method in correcting artifacts. 
The MC may take significant amount of time for artifact correction, and therefore, software 
packages like Kubios HRV offers automatic correction methods including the TBC and AC, which 
has been only available since 2017 with Kubios HRV Premium (ver 3.0). Previously, Giles et al., 
(2017) showed that the TBC of Kubios HRV (ver 2.2) did not properly correct the artifacts even 
though the software accurately identified the artifacts. Specifically, TBC of Kubios HRV (ver 2.2) 
replaced T4 error containing two missed beats with one interval rather than the required two. The 
same issue with T4 correction is still present with Kubios HRV Premium (ver 3.2). We observed 
that the AC, which was not available with Kubios HRV (ver 2.2) properly corrected the T4 errors 
containing two missed beats, the erroneous beat was replaced with the required two intervals. 
However, the AC was not able properly correct T4 errors containing >2 missed beats, the erroneous 
beat was replaced with one interval rather than the required >2 intervals. The problems in both AC 
and TBC in correcting T4 errors may explain why both methods resulted in larger biases and ESs, 
wider LoA ranges, and lower ICCs than those of the MC and ECG in the current study.  
75 
 
In addition to the issues with T4 error correction, the AC appears to always overcorrect 
three intervals at the beginning and the end of a sample regardless of the artifact condition. This 
may explain why the TBC performed better in correcting artifacts with smaller bias (1.16 versus 
3.79 ms), tighter LoA ranges ( -92.67 to 94.98 versus -130.32 to 137.90 ms), and higher ICC (0.95 
versus 0.9) than the AC when both methods were compared. Nevertheless, the TBC of Kubios 
HRV Premium (ver 3.2) produced higher bias (1.6 versus 0.1 ms) and wider LoA ranges (-92.67 
to 94.98 versus -0.15 to +0.24 ms) among adults with hypertension than the TBC of Kubios HRV 
(ver 2.2) among healthy individuals (Giles et al 2017). Since automatic correction methods in 
general perform better among healthy individuals with small number of artifacts (Peltola et al., 
2012) higher error rate in the current study may explain the differences in R-R interval results.  
 Moreover, time, frequency, and non-linear HRV measures calculated from the Polar 
V800TM  R-R intervals corrected by the MC and those calculated from ECG showed excellent 
agreeability and interchangeability with consistent small biases, tight LoA ranges, trivial ES (i.e., 
ES <0.2, (Cohen et al., 2013), and excellent ICCs (i.e., ICC>0.90, Koo and Li, 2016), similar to 
levels of agreeability and interchangeability found in previous studies with the Polar V800TM Giles 
et al (2016) and Polar S810TM Gamelin et al., (2006). When time domain HRV measures (SDNN, 
RMSSD, and pNN50%) derived from the Polar V800TM and ECG were compared, excellent 
agreement was found with small biases, tight LoAs, ICCs in all cases 1.00 and trivial ESs.  The 
biases of the MC SDNN, RMSSD, and pNN50% (i.e., measures calculated from the Polar V800TM  
R-R intervals corrected by the MC) were all < 1 ms, consistent with those reported by Giles et al.,  
(2016) and Gamelin et al., (2006). The LoA ranges obtained for the MC SDNN (-0.70 to +1.12 
ms), MC RMSSD (-1.82 to +2.18 ms), and MC pNN50% (-1.52 to +1.30 ms)  were slightly higher 
than those reported by Giles et al., (2016) [(SDNN: -0.22 to +0.24 ms), (RMSSD: -0.32 to +0.32 
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ms), and (pNN50%: -1.20 to +0.70 %)] and Gamelin et al., (2006) [(SDNN: -0.47 to +0.63), 
(RMSSD: -1.17 to +1.58 ms), and (pNN50%:-2.47 to 3.04%)].  The ESs and ICCs of the MC 
SDNN, RMSSD, and pNN50% in the current study, Giles et al., (2016), and Gamelin et al., (2006) 
were trivial and excellent, respectively.  
The frequency domain measures (LFms2, LFnu, HFm2, HFnu, and LF/HF) calculated from 
Polar V800TM R-R intervals corrected by the MC displayed good agreement when compared with 
the corresponding ECG HRV measures. The biases of the MC LFms2 (6.85 ms2) and HFms2 (9.94 
ms2) in the current study were higher than those reported by Giles et al., (2016) [(LFms2: -0.95 
ms2) and (HFms2: 0.45 ms2)] and Gamelin et al., (2006) [(LFms2: 0.06 ms2) and (HFms2: 0.39 
ms2)]. Nonetheless, the ICCs between the Polar V800TM and ECG were excellent and the ESs were 
trivial ES (ES of LFms2 < 0.005; ES of HFms2) for both LFms2 and HFms2. On the other hand, 
biases of LFnu, HFnu, and LF/HF ratio were all <0.50, similar findings to those reported by Giles 
et al (2016) and Gamelin et al (2006). The LoA ranges obtained for the MC LF ms2 (-65.77 to 
+79.48 ms2 ), MC HF ms2 (-44.20 to +64.07 ms2 ), MC LFnu (-1.68 to 0.98), MC HFnu (-0.98 to 
+1.68), and LF/HF (-0.23 to +0.14) were wider than those reported by Giles et al (2016) [LFms2: 
-6.25 ms2 +4.36), (HF ms2: -27.95 to 28.84), LFnu: (-0.72 +0.56), HFnu: (-0.57 to +0.72), and 
LF/HF (-0.43 to +0.35)] and Gamelin et al., (2006) [LFms2:-5.82 +5.94) ,(HFms2: -8.63 +9.42), 
and LF/HF: -0.18 +0.13)]. However, LoA ranges obtained for MC LFnu (-1.68 to 0.98) and MC 
HFnu (-0.98 to +1.68) were tighter than those reported by Gamelin et al., (2006) [LFnu:-1.90 
+1.96) and (HFnu: -1.96 + 1.90). The ESs and ICCs of the MC LF ms2, HF ms2, LFnu, HFnu, and 
LF/HF in the current study, Giles et al., (2016), and Gamelin et al., (2006) were all trivial and 
excellent, respectively. However, when the MC was compared to the TBC and AC, the biases of 
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LFms2, LFnu, HF ms2, and HFnu were larger in the MC. Nonetheless, the trivial ESs and excellent 
ICCs were present between these variables of Polar V800TM and ECG.   
The non-linear measures (SD1, SD2, and SD2/SD1) calculated from Polar V800TM R-R 
intervals corrected by the MC also displayed excellent agreement when compared with ECG. The 
biases of MC SD1 and SD2 were <0.50, similar findings to those reported by Giles et al., (2016) 
and Gamelin et al., (2006) who did not report SD2/SD1 ratio. The bias (0.01) and LoA range (-
0.14 to +0.15) of SD2/SD1 ratio in the current study showed that SD2/SD1 is highly agreeable 
with that of ECG. The LoA range for SD1 (-1.29 +1.54) and SD2 (-0.55 +0.97) were slightly 
higher than those reported by Giles et al (2016) [(SD1: -0.21 +0.23) and (SD2: -0.20 +0.24)] and 
Gamelin et al 2006 [(SD1:-0.85 +1.15)  and (SD2: -0.56 +0.60)].   
With the exception of LFms2 and HFm2, the biases (<1 ms), ESs (<0.2), and ICCs (>0.96) 
of the all HRV measures calculated from the Polar V800TM  R-R intervals corrected by the TBC 
of Kubios HRV Premium (ver3.2) and those calculated from the Polar V800TM  R-R intervals 
corrected by the TBC (only option) of Kubios HRV (ver2.2) in Giles et al (2017) were highly 
consistent. However, LoA ranges for the TBC SDNN (-10.59 to 9.49 ms), the TBC RMSSD (-9.57 
to 10.63 ms), and the pNN50% (-1.33 to 1.02%) were noticeably wider than those reported by 
Giles et al (2017) [(SDNN: -0.25 +0.24), RMSSD: (-0.69 +0.51), and pNN50% (-0.64 +0.72)]. 
Additionally, the LoA ranges for TBC LF ms2 (-275.86 to 287.59), TBC HF ms2 (-460.59 to 
534.74), TBC LFnu (-4.04 to 4.01), TBC HFnu (-4.01 to 4.04), and LF/HF (-0.79 to 1.02) were 
substantially wider than those reported by Giles et al., (2017) [(LF ms2: -15.34 to 12.2 ms2),  HF 
ms2: (-36.11 to 29.077 ms2), LFnu: (-0.82 to 0.672), HFnu: (-0.67 to 0.821), and LF/HF: (-0.23 to 
0.18)]. Moreover, the LoA ranges obtained for TBC SD1 (-6.78 to 7.53) and TBC SD2 (-14.39 to 
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12.21) were also markedly wider than those reported by Giles et al (2017) [(SD1: -0.49 to 0.36 
ms) and (SD2: -0.19 to 0.17 ms)].  
The biases of AC SDNN (-1.60 ms), AC RMSSD (2.13), AC pNN50% (0.51%), AC LF 
nu (0.57), AC HF nu (-0.57), AC LF/HF (0.12), AC SD1 (1.51), AC SD2 (-2.97), and AC SD2/SD1 
(-0.07) were larger than those of the TBC with the exception of AC LF ms2 (0.80 ms2) and AC HF 
ms2 (-8.27 ms2). In addition, the LoA ranges obtained for AC SDNN (-23.27 to 20.06), AC 
RMSSD (-25.57 to 29.84), AC pNN50% (-7.28 to 8.29), AC LF ms2 (-369.45 to 371.06), AC HF 
ms2 (-1115.84 to 1099.293), AC LF nu (-24.29 to 25.44), AC HF nu (-25.44 to 24.29), AC LF/HF 
(-1.76 to 2.00), AC SD1 (-18.12 to 21.14), AC SD2 (-26.11 to 20.17), and AC SD2/SD1 (-1.01 to 
0.87) were substantially wider than those of the TBC method in the current study. Overall, both 
methods of Kubios HRV Premium (ver 3.2) had many of HRV measures outside of the LoA 
ranges, suggesting that individual HRV measures are not valid while group HRV measures could 
be acceptable with small biases, trivial ESs, and moderate to excellent ICCs.   
5.1. Conclusion 
This is the first reporting that validated the Polar V800TM HR monitor in detecting R-R 
intervals and producing agreeable and interchangeable HRV measures in clinical populations, 
specifically in adults with hypertension. Of note, however, researchers should edit raw Polar 
V800TM R-R intervals with an appropriate correction method to decrease bias and LoA ranges and 
thus to obtain valid HRV measures. Hypertension may be responsible for higher error rate, biases 
and wider LoA ranges in R-R intervals and HRV measures in the current study compared to those 
reported in healthy individuals since compromised autonomic function reduces R-wave amplitude, 
making the detection of R-R intervals difficult for Polar V800TM HR monitor. Therefore, 
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correction of R-R intervals with artifacts among adults with hypertension is of higher importance 
than that of healthy individuals.    
We recommend researchers to choose the MC as a first option for correcting Polar V800TM 
artifacts because of the tightest LoA ranges, smallest ESs, and excellent ICCs of 1 for all HRV 
measures observed with the MC compared to the Kubios HRV Premium (ver 3.2) methods. 
Researchers can identify and correct the artifacts following the current guidelines (i.e., the MC) 
detailed in chapter 2 without the simultaneously recorded ECG. However, Kubios HRV Premium 
(ver 3.2) can be a second option for those who may find the MC complicated and laborious. In that 
case, the TBC should be preferred over the AC as the TBC produced smaller biases than the AC 
for all HRV measures with the exception of LF ms2 and HFms2 as well as tighter LoAs, and smaller 
ESs for all HRV measures. Since both automatic correction methods produced invalid individual 
HRV measures as substantial number of values were outside of LoA ranges researchers should 
only report group HRV measures when using Kubios HRV Premium (ver 3.2) for artifact 
correction. In addition, the previously described issues with the TBC and AC correction methods 
should be addressed in the next versions of Kubios HRV software packages in order to improve 
the data accuracy of HRV measures derived from Polar V800TM in adults with hypertension.  
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